Opendata, web and dolomites
H2020 projects about "drug"
The page lists 1334 projects related to the topic "drug".
| # | |||
|---|---|---|---|
| 1 | FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 |
| 2 | MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients | 2015 |
| 3 | IDEAS | Improving Design, Evaluation and Analysis of early drug development Studies | 2015 |
| 4 | DiaChemo | Point-of-care microfluidic device for quantification of chemotherapeutic drugs in small body fluid samples by highly selective nanoparticle extraction and liquid crystal detection | 2015 |
| 5 | OPERAM | OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly | 2015 |
| 6 | BETA3_LVH | A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease | 2015 |
| 7 | VIROGENESIS | Virus discovery and epidemic tracing from high throughput metagenomic sequencing | 2015 |
| 8 | MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 |
| 9 | Paragone | PARAGONE: vaccines for animal parasites | 2015 |
| 10 | COMPUCELL | Autonomous Cellular Computers for Diagnosis | 2015 |
| 11 | Highland Connections | Remoteness and Connectivity: Highland Asia in the World | 2015 |
| 12 | ROBOTAR | Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents | 2015 |
| 13 | SM-IMPORT | Substrate import at work: single-molecule studies of ABC transporters | 2015 |
| 14 | SILENCE | Mechanisms of Gene Silencing by the Glucocorticoid Receptor | 2015 |
| 15 | aLzINK | Alzheimer's disease and Zinc: the missing link ? | 2015 |
| 16 | LimitMDR | Utilizing evolutionary interactions to limit multidrug resistance | 2015 |
| 17 | Weakinteract | Weak interactions in self-organizations studied by NMR spectroscopy in the supramolecular solid-state | 2015 |
| 18 | DE-ORPHAN | DEtermination of Orphan Receptor PHysiological Agonists and sigNals | 2015 |
| 19 | PhilPharm | Philosophy of Pharmacology: Safety, Statistical standards and Evidence Amalgamation | 2015 |
| 20 | CatHet | New Catalytic Asymmetric Strategies for N-Heterocycle Synthesis | 2015 |
| 21 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 22 | VEGFDANI | Novel enhancers of functional recovery after stroke | 2015 |
| 23 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 24 | QUCHIP | Quantum Simulation on a Photonic Chip | 2015 |
| 25 | eDrug | Drug eDesign: Building the next generation of software solutions for drug design | 2015 |
| 26 | IMPARTS | Integral Membrane Proteins – an Approach to Rank Target Stability | 2015 |
| 27 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 |
| 28 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 29 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 30 | ClickGene | Click Chemistry for Future Gene Therapies to Benefit Citizens, Researchers and Industry | 2015 |
| 31 | MET-A-FOR | Metabolomic analysis for the forensic detection of drugs of abuse in performance and food producing animals | 2015 |
| 32 | TargetCaRe | Targeting Cartilage Regeneration in joint and intervertebral disc diseases | 2015 |
| 33 | ANTIVIRALS | European Training Network on Antiviral Drug Development | 2015 |
| 34 | EUROLEISH-NET | Control of leishmaniasis, from bench to bedside and community | 2015 |
| 35 | MULTI-APP | Multivalent Molecular Systems for Innovative Applications | 2015 |
| 36 | HyMedPoly | Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications | 2015 |
| 37 | iManageCancer | iManageCancer - Empowering patients and strengthening self-management in cancer diseases | 2015 |
| 38 | RETHRIM | Restoring tissue regeneration in patients with visceral Graft versus Host Disease. | 2015 |
| 39 | SC0806 | Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts | 2015 |
| 40 | REDOXIT | Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils. | 2015 |
| 41 | CRYDIS | Driving innovation in pharmaceuticals: integrated studies of physical dissolution properties of crystalline and amorphous forms using enhanced orthogonal monitoring techniques | 2015 |
| 42 | ChemoEnz | Chemo-Enzymatic Manufacturing Routes to High- Value compounds | 2015 |
| 43 | OCN4OS | Organo-Catalytic Nanoparticles for Organic Synthesis | 2015 |
| 44 | HYMADE | Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes | 2015 |
| 45 | NEXT-3D | Next generation of 3D multifunctional materials and coatings for biomedical applications | 2015 |
| 46 | NanoPilot | A Pilot Plant for the Production of Polymer based Nanopharmaceuticals in Compliance with GMP | 2015 |
| 47 | SMPFv2.0 | Next generation single molecule protein fluorescence | 2015 |
| 48 | R2R Biofluidics | Large scale micro-and nanofabrication technologies for bioanalytical devices based on R2R imprinting | 2015 |
| 49 | TUSUPO | Tubular Supramolecular Polymers: A new class of therapeutic polymers | 2015 |
| 50 | GROWMOF | Modelling of MOF self-assembly, crystal growth and thin film formation | 2015 |
| 51 | BIZEB | Bio-Imaging of Zoonotic and Emerging Bunyaviruses | 2015 |
| 52 | CVDTEU | Clinical validation of the DiviTum assay in key European markets | 2014 |
| 53 | Accellta | Accellta Market Study | 2014 |
| 54 | FIND | Feasibility Assessment of a Foot INflammation Detection Device | 2014 |
| 55 | COMBPDCHEMOTHERAPY | Rational design of combined PDT photosensitizers and chemotherapeutic agent as new approach in cancer therapy: a computational approach | 2015 |
| 56 | LAW-TRAIN | Mixed-reality environment for training teams in joint investigative interrogation-Intelligent interrogation training simulator | 2015 |
| 57 | microMole | SEWAGE MONITORING SYSTEM FOR TRACKING SYNTHETIC DRUG LABORATORIES | 2015 |
| 58 | iNEXT | Infrastructure for NMR, EM and X-rays for translational research | 2015 |
| 59 | Aggregation selection | Genome-wide screen of aggregation selection | 2015 |
| 60 | SalHyd5 | Characterization of Salmonella enterica hydrogenase-5 biosynthesis for developing novel anti-infective compounds | 2015 |
| 61 | FLUNOVELTY | Development of novel fluorinated reagents for preparation of drugs. | 2015 |
| 62 | TentaclesOfVenom | Unravelling the enigmatic origin of venom secreting cells in sea anemone | 2015 |
| 63 | MOSUDO | Water and Drug Mobility at Silica Surfaces probed with DOSY NMR | 2015 |
| 64 | Cancer-Drug-Screen | High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor | 2015 |
| 65 | WITHDRAWAL AFTERMATH | The Aftermath of a Drug Withdrawal: Modeling Spillover Effects Across Countries and Across Categories | 2015 |
| 66 | EPINET | Detection of brain patterns for the characterisation of epileptic networks | 2015 |
| 67 | CONSORT | Controlled Singlet Oxygen Release Photosensitizers in Photodynamic Therapy | 2015 |
| 68 | Bump-BET | Bump and Hole approach to elucidate function of individual bromodomains of BET proteins | 2015 |
| 69 | ISOTRAPSS | Isoform specific inhibition by transient protein state stabilization | 2015 |
| 70 | CheliceLand | Molecular palaeobiology and comparative genomics of chelicerate terrestrialisation | 2015 |
| 71 | PoreSelect | Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoprotein | 2016 |
| 72 | MagProtoCell | Magnetic micromachines based on protocell design and engineering | 2015 |
| 73 | ELSWIFLUOPRO | Electrochemically Switchable Fluorescent Probes for Biological Applications | 2015 |
| 74 | INSCAPE | Imaging Voltage Gated Sodium Channels Using Positron Emission Tomography | 2015 |
| 75 | NPL | Synthesis of Natural Product Like Compounds for Drug Discovery | 2016 |
| 76 | GLUCOTOX | Does reducing β-cell glucotoxicity increase the hyperglycaemia-lowering effect of physical exercise in type 2 diabetes? | 2015 |
| 77 | Class II PI3K | Characterization of the signalling and physiological roles of the class II PI3Ks | 2016 |
| 78 | CHELALZ | Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies | 2016 |
| 79 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 80 | SilentFACT | Functional networks and cancer roles of the essential histone chaperone FACT | 2015 |
| 81 | ICSIS | The interaction and clearance of senescent vascular cells by the innate immune system | 2015 |
| 82 | RAPID-KDM | Application of peptide screening technology for identification of substrates of the Jumonji-C histone demethylases | 2015 |
| 83 | PneumoCompetence | Unravelling the mechanisms of competence induction by antibiotic stress in Streptococcus pneumoniae | 2015 |
| 84 | Nano Structured Emulsion Foods | AYURVEDIC BIOACTIVE COMPOUNDS STABILIZED PICKERING DOUBLE EMULSIONS- FABRICATION AND IN VITRO EVALUATION | 2015 |
| 85 | NAP-QDYS | Nitroaromatics photophysics and photochemistry: a quantum dynamics study | 2016 |
| 86 | MHAtriCell | Hyaluronan-rich matrices crosslinked with collagen-like peptides for 3D culture of ovarian cancer cells | 2015 |
| 87 | MSMART | Margination of Microcapsules in Small Arteries | 2015 |
| 88 | CARiPSCTcells | Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application | 2015 |
| 89 | VECTORIGAMI | DNA Origami for drug delivery | 2015 |
| 90 | ChemoBOOM | Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy | 2016 |
| 91 | MYO-DESMOPLASIA | Modulating the behaviour of cancer myofibroblasts to control tumour desmoplasia | 2015 |
| 92 | Micropod | MICROPOrous Devices for next-generation therapeutic delivery | 2015 |
| 93 | Als-on-a-chip | A tissue-on-a-chip platform for systems-level studies of ALS pathology and drug screening | 2015 |
| 94 | TWISTER | ToWards the Identification of Sesquiterpene TransportERs | 2015 |
| 95 | PHELLINI | Plasmonic Heaters Linked to Lanthanide-Based Nanothermometers for Photodynamic Therapy in the Near-Infrared | 2015 |
| 96 | GENMETASTEM | GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS | 2016 |
| 97 | BAP | A dynamical view of binding affinity | 2015 |
| 98 | MACROIMAGING | Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages | 2015 |
| 99 | AND | Antibacterial (Nano)medicines Development | 2015 |
| 100 | VesSenDrugDeliv | A versatile platform for the design of targeting drug delivery vesicles | 2015 |
| 101 | NovLeuReg | Identification and characterization of novel essential regulators of acute myeloid leukemia | 2016 |
| 102 | SELECT-A-PROTEIN | Mixed brushes of stimuli-responsive polymers for the selective adsorption of proteins | 2015 |
| 103 | MetalCell | Transition-Metal Mediated Chemistry in Cells | 2015 |
| 104 | IPEIBD | Identification of promoters and enhancers specific for inflammatory bowel disease and its subtypes | 2015 |
| 105 | MCMQCT | Multi-functional Computational Microscopy for Quantitative Cell Tracking | 2015 |
| 106 | BactoDrug | The Bacteroides dual-pumping membrane-integral pyrophosphatase: a novel drug target | 2015 |
| 107 | VascColl | Temporally controlled delivery of vascular therapeutics from a regenerative template for diabetic wound healing | 2015 |
| 108 | MEMBRANEPROT | Membrane proteins – development of new computational approaches and its application to G-Protein Coupled Receptors | 2016 |
| 109 | BRIDGES | Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients | 2015 |
| 110 | FUNC NGS | Deep screening of proteins with a next generation sequencing platform | 2015 |
| 111 | PRe-FActo | Periodontal Regeneration through Femtosecond laser Action | 2016 |
| 112 | MDR Tuberculosis | Evolution and success of the multi-drug resistant M. tuberculosis SIT41 (LAM7-TUR) lineage | 2015 |
| 113 | depreg | Antidepressants during pregnancy: underlying mechanisms associated with neurodevelopmental outcome | 2015 |
| 114 | OPTOFRAX | Optopharmacological brain mapping of autism mouse models | 2015 |
| 115 | Lx Micelles | Coordination chemistry in doubly stabilized micelles for the tageted delivery of cytostatic drugs in cancer therapy | 2015 |
| 116 | WntTraffic | Characterising the spatial organisation and regulation of the Wnt receptor complex in stem cells and cancer | 2016 |
| 117 | MetAccembly | Accelerating metal-directed assembly, recognition and catalysis with computational methods | 2015 |
| 118 | FOLDASYNBIO | Bioinspired Nanostructures by Self-assembly of Amphiphilic Non-peptide Helical Foldamers in Aqueous Environment | 2015 |
| 119 | REBuILD | Exploring the role of TFEB in exosome biology and in novel approaches for treatment of lysosomal diseases | 2016 |
| 120 | G4invivo | Probing intracellular folding and dynamics of telomeric DNA structures with single-molecule FRET | 2016 |
| 121 | STTDAA | Synthesis of Truncated Tirandamycin A-D Derivatives as new Antihelminthic Agents | 2015 |
| 122 | DrugsUP | Solute carrier proteins and the uptake of cytotoxic approved drugs | 2015 |
| 123 | HumEnBody | Responding to the Trend of Human Enhancement Drugs: the Case of Drug-Free Bodybuilding Culture in European Context | 2015 |
| 124 | PReDicT | Predicting Response to Depression Treatment | 2015 |
| 125 | SENSITIVITYMARKERS | Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies | 2015 |
| 126 | BIOTIMA | Market Opportunity Confirmation for Biomimetic Tissue Matrix Products | 2015 |
| 127 | Cardiacom IMPLANT | Intelligent human diagnostic and therapy platform | 2014 |
| 128 | eMediCare2 | Promoting sustainable patient treatment by an intelligent online medicine dispenser for home care use. | 2015 |
| 129 | CASI | AN INTEGRATED AUTOMATED ECG DIAGNOSTICS PLATFORM TO IMPROVE CARDIAC SAFETY IN CLINICAL DRUG TRIALS | 2015 |
| 130 | Multidyn | Patented advanced low-cost multiwell cell-culture system for in-vitro physiologically relevant biomarker screening | 2015 |
| 131 | IONOSENSE-POC | Exploitation of Organic Electrochemical Transistors for Biological Ionsensing – Proof Of Concept | 2015 |
| 132 | RodBot | Automated Microhandling System for X-ray Crystallography | 2015 |
| 133 | ACOFORS | Launching Acoustic Force Spectroscopy - unlocking the potential of biomolecular bungee jumping | 2015 |
| 134 | REACTION | Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 |
| 135 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
| 136 | DEALS | Biomarker assay development to expedite ALS experimental therapeutic advancement | 2015 |
| 137 | FACTs | Fast Acting Virus Control Strategies for Production Animal Diseases | 2015 |
| 138 | USODA | Upscaling Synthesis of Ordered mesoporous silica material for Drug delivery Applications | 2015 |
| 139 | STROBE | Sustained Release Ocular Bevacizumab for the treatment of wet acute macular degeneration | 2015 |
| 140 | PANOSTICS | The AA2-Ratio: A Novel Diagnostic Biomarker for Primary Aldosteronism | 2015 |
| 141 | XPRESSO | Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery. | 2015 |
| 142 | Lipid | The untapped potential of omega-3; from fish oil to healthy bowels | 2015 |
| 143 | ATRS Instrument | Real time analysis of tablet and capsule dosage during pharmaceutical manufacturing | 2015 |
| 144 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 145 | MEDICIS-PROMED | MEDICIS-produced radioisotope beams for medicine | 2015 |
| 146 | INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | 2015 |
| 147 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 148 | MtbTransReg | Translational regulation in the persistence and drug susceptibility of Mycobacterium tuberculosis | 2015 |
| 149 | DRIVE | Diabetes Reversing Implants with enhanced Viability and long-term Efficacy | 2015 |
| 150 | NOSY | New Operational Sensing sYstem | 2015 |
| 151 | ORGANO-GOLD CAT | Merging organo- and gold-catalysis to design cascade reactions: a shortcut toward molecular complexity | 2015 |
| 152 | PREVENT | Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment | 2015 |
| 153 | CHROMAVISION | Super-resolution visualisation and manipulation of metaphase chromosomes | 2015 |
| 154 | INCIPIT | INnovative Life sCIence Phd Programme in South ITaly | 2016 |
| 155 | DermalTherapy | Membrane fusion mediated dermal allergy immunotherapy | 2015 |
| 156 | NanoPoreFab | On-chip fabrication of solid state nanopores for high throughput single molecule analysis | 2015 |
| 157 | HTMD | Feasibility assessment of a cloud application platform for rational drug design using high throughput molecular dynamics | 2015 |
| 158 | DERMADROP | DERMADROP - A COMPREHENSIVE TRANSDERMAL THERAPY CONCEPT FOR NON- HEALING WOUNDS AND OTHER SKIN DISORDERS | 2015 |
| 159 | ER_disease | Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer | 2015 |
| 160 | OsteomiR | OsteomiR-Test – An In-Vitro Test for the Diagnosis of Osteoporosis and associated Fracture Risk | 2015 |
| 161 | RIPEB | Rapid heat inactivation of pathogens to enable biomarker research | 2015 |
| 162 | ZF-MEL-CHEMBIO | Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma | 2015 |
| 163 | E-SPACE | European Standardised Process Approach to Cognitive Evaluation in older people | 2016 |
| 164 | ActIng | Addiction of Insects for Biosensoring | 2015 |
| 165 | PULTAR | Delivery of PULmonary Therapeutics through TARgetted Delivery using Phononics | 2015 |
| 166 | platinDx | A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients. | 2015 |
| 167 | MIMIC | Mimicking organs on chips for high throughput drug screening and basic research | 2016 |
| 168 | C-POC | Hyper/Hypo Coagulability Assessment Photonic Integrated Chip based Point of Care | 2015 |
| 169 | NANOSHOCK | Manufacturing Shock Interactions for Innovative Nanoscale Processes | 2015 |
| 170 | BIOINOHYB | Smart Bioinorganic Hybrids for Nanomedicine | 2016 |
| 171 | RENOIR | RENal prOgenItoRs as tools to understand kidney pathophysiology and treat kidney disorders | 2015 |
| 172 | NeuroNanoChip | A Nano-electrode chip for high-resolution/high-throughput cellular assays in cultured neurons including synaptic tranmission | 2015 |
| 173 | SAMPA | Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application (SAMPA). | 2015 |
| 174 | ADIPOR | Molecular and structural pharmacology of adiponectin receptor: towards innovative treatments of obesity-related diseases. | 2015 |
| 175 | ADDIA | Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease | 2015 |
| 176 | PROGSY | Prosaposin and GPR37 in synucleinopathies | 2015 |
| 177 | Drug-Seq | Unravelling the Genomic Targets of Drugs Using High-Throughput Sequencing | 2015 |
| 178 | TRIGGDRUG | Reactions That Translate mRNA into Drug-like Molecules | 2016 |
| 179 | VARMET | Variational Metadynamics | 2016 |
| 180 | ASPIRE | Angular studies of photoelectrons in innovative research environments | 2016 |
| 181 | NANOTRANS | TRANSPORT OF SOFT MATTER AT THE NANOSCALE | 2016 |
| 182 | ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | 2015 |
| 183 | AFib-TrainNet | EU Training Network on Novel Targets and Methods in Atrial Fibrillation | 2015 |
| 184 | Phd | Deciphering PI3K biology in health and disease | 2015 |
| 185 | MOGLYNET | Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study | 2015 |
| 186 | BioExcel | Centre of Excellence for Biomolecular Research | 2015 |
| 187 | HaemMetabolome | Deciphering the Metabolism of Haematological Cancers | 2015 |
| 188 | SyDAD | Synaptic Dysfunction in Alzheimer Disease | 2015 |
| 189 | HisMoDetect | An Antibody Microarray for Histone Modifications | 2015 |
| 190 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 191 | IonoChem | IonoChem: A new and highly efficient cross membrane drug delivery strategy | 2015 |
| 192 | INTESTINANOS | Intestinal Lipoidal Nanostructures - A Lipid Bridge to Increased Drug Delivery | 2015 |
| 193 | NOC2D | Nucleation of Organic Crystals onto 2D materials | 2015 |
| 194 | AMORPHORM | New stability testing method to predict the performance of amorphous formulations | 2016 |
| 195 | ISOTOPICS | ISOTOPIC LABELING FOR DRUG INNOVATION | 2016 |
| 196 | AEGIS | Accelerated Early staGe drug diScovery | 2016 |
| 197 | FRAGNET | FRAGments training NETwork | 2016 |
| 198 | STEMCARDIORISK | Stem Cells for Cardiac Arrhythmia Risk Assessment | 2015 |
| 199 | REGMAMKID | How to regenerate the mammalian kidney | 2015 |
| 200 | SEGWAY | Study on Environmental and GenomeWide predictors of early structural brain Alterations in Young students | 2015 |
| 201 | CRADLE | Cancer treatment during pregnancy: from fetal safety to maternal efficacy | 2015 |
| 202 | M-Imm | Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells | 2015 |
| 203 | resistance evolution | Bacterial evolution of hypersensitivity and resistance against antimicrobial peptides | 2015 |
| 204 | AVATAR | Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment | 2015 |
| 205 | COMbAT | Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies | 2015 |
| 206 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
| 207 | CellScreenChip | All-in-One Cell Screening Chip: Device for Affordable High-Throughput Cell Screenings | 2015 |
| 208 | JPI-EC-AMR | ERA-NET for establishing synergies between the Joint Programming Initiative on Antimicrobial Resistance Research and Horizon 2020 | 2015 |
| 209 | NISCI | Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European clinical proof of concept trial | 2016 |
| 210 | BIOVALID | Clinical validation of the DiviTum assay in two high profile clinical studies in Europe | 2015 |
| 211 | Ocean Medicines | Ocean Medicines | 2015 |
| 212 | PRETREAT | PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform | 2016 |
| 213 | LUCY | Early detector of comorbid depression | 2015 |
| 214 | ANAPRINT | Additive Printing for Cell-Based Analysis | 2015 |
| 215 | DrugStop | Drug detection for personal protection | 2015 |
| 216 | MSmed | Mass spectrometric technology for next generation proteomics in systems medicine | 2015 |
| 217 | FAST-DEVELOPS | Developing new therapeutics for Friedreich ataxia | 2015 |
| 218 | QuatSalts | New Quaternary Ammonium Salts for use in Drug Manufacture | 2016 |
| 219 | PANG | Pathogen and Graphene | 2016 |
| 220 | SMART | SMART: Small Medicines Advanced Research Training | 2016 |
| 221 | F-CCW | Functional Cell Culture Ware (F-CCW) : Technical and Commercial feasible? | 2015 |
| 222 | DILITEST | Diagnosis and Exclusion of Drug-Induced Liver Injury by using Patient Blood Samples (DILITEST) | 2015 |
| 223 | DYNAP | Dynamic Penetrating Peptide Adaptamers | 2016 |
| 224 | AGS | A resource-efficient granulation process for advanced formulation of any compound in food and pharma production | 2015 |
| 225 | CODIC | COmmercializing first-in-class dCTPase Inhibitors for treatment of hematological Cancers | 2016 |
| 226 | COMIET | Engineering Complex Intestinal Epithelial Tissue Models | 2015 |
| 227 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 228 | SCIDNET | DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) | 2016 |
| 229 | VISION DMD | VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy | 2016 |
| 230 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 |
| 231 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 232 | MYOCURE | Development of an innovative gene therapy platform to cure rare hereditary muscle disorders | 2016 |
| 233 | FORCE | Imaging the Force of Cancer | 2016 |
| 234 | U-PGx | Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen | 2016 |
| 235 | Click-It | “In Vivo Click PET Imaging Agents”: Improving clinical companion diagnostics | 2016 |
| 236 | SysMedPD | Systems Medicine of Mitochondrial Parkinson’s Disease | 2015 |
| 237 | ATLAS | Bioengineered autonomous cell-biomaterials devices for generating humanised micro-tissues for regenerative medicine | 2015 |
| 238 | ADOPT BBMRI-ERIC | implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC | 2015 |
| 239 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 240 | CONQUEST | Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies | 2016 |
| 241 | COBIOPHAD | COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS | 2016 |
| 242 | MEDLEM | Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments | 2016 |
| 243 | FutForm | Future Formulations: Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral Exchange | 2016 |
| 244 | CHEM2NATURE | Enabling precision chemical methodologies applied to natural-based systems for the development of multifunctional biomedical devices | 2016 |
| 245 | SCHISTO_PERSIST | New approaches to characterise Schistosoma mansoni infections persisting despite mass drug administration | 2016 |
| 246 | BIOACTIVECOATINGS | BioActive Coatings in multi-well cell culture plates | 2016 |
| 247 | SponGES | Deep-sea Sponge Grounds Ecosystems of the North Atlantic: an integrated approach towards their preservation and sustainable exploitation | 2016 |
| 248 | SAFEIMMUNOSUPPRESS | Development of immunosuppressive treatments with better safety | 2016 |
| 249 | FOLSMART | Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis | 2016 |
| 250 | ERAD_SELMA | Mechanisms of protein translocation in ER-associated protein degradation and the related protein import into the apicoplast of Plasmodium falciparum | 2016 |
| 251 | PolyDrug Discovery | Discovery of anticancer polymeric drugs that mimic the action of TRAIL | 2016 |
| 252 | FLAIR | Flexible Hyperspectral Infrared Detectors | 2016 |
| 253 | PrECISE | PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION | 2016 |
| 254 | EDEN2020 | Enhanced Delivery Ecosystem for Neurosurgery in 2020 | 2016 |
| 255 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
| 256 | HYBOCOMIX | Hydrogen bonds in diblock copolymer/ homopolymer melt | 2016 |
| 257 | PEARRL | Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines | 2016 |
| 258 | ENHANCE | Engineering the 3D Niche to enHANCE functionality of hepatocytes derived from human iPSCs | 2016 |
| 259 | ICARO | Colloidal Inorganic Nanostructures for Radiotherapy and Chemotherapy | 2016 |
| 260 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 261 | RITA-MI | Rituximab in Acute Myocardial Infarction | 2016 |
| 262 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 263 | channelopathies | Type 1 reyanodine receptor Structure and regulation by post-translational modifications and small molecules. | 2016 |
| 264 | HyGlio | Theranostic Injectable Hydrogel for Glioblastoma | 2016 |
| 265 | CaNANObinoids | From Peripheralized to Cell- and Organelle-Targeted Medicine: The 3rd Generation of Cannabinoid-1 Receptor Antagonists for the Treatment of Chronic Kidney Disease | 2016 |
| 266 | ReachingCompleteness | The Molecular Basis of Somatic Nuclear Reprogramming | 2016 |
| 267 | ComplexSwimmers | Biocompatible and Interactive Artificial Micro- and Nanoswimmers and Their Applications | 2016 |
| 268 | RespMicroFlows | Unravelling respiratory microflows in silico and in vitro: novel paths for targeted pulmonary delivery in infants and young children | 2016 |
| 269 | PEP-PRO-RNA | Peptide-derived bioavailable macrocycles as inhibitors of protein-RNA and protein-protein interactions | 2016 |
| 270 | DAPP | Data-centric Parallel Programming | 2016 |
| 271 | inHForm | Integrative omics of heart failure to inform discovery of novel drug targets and clinical biomarkers | 2016 |
| 272 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 273 | QUESS | Quantum Environment Engineering for Steered Systems | 2017 |
| 274 | RiboDisc | Discovery of novel orphan riboswitch ligands | 2016 |
| 275 | NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy | 2016 |
| 276 | CanPathPro | Generation of the CanPath prototype - a platform for predictive cancer pathway modeling | 2016 |
| 277 | hRBP-virion | Comprehensive identification of host factors involved in the early steps of HIV infection. | 2017 |
| 278 | MinBioTag | A minimal Cys-cyclobutene non-canonical amino acid for bioorthogonal imaging of proteins in live cells | 2016 |
| 279 | BEAMED | Better Addiction Medicine Education for Doctors | 2017 |
| 280 | microMAGNETOFLUIDICS | 3D-printed magnetic microfluidics for applications in life sciences | 2016 |
| 281 | PHOTO ORGANO-GOLD | Driving asymmetric photoreactions by merging organo- and gold-catalysis | 2016 |
| 282 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
| 283 | DynamAtt | Dynamics of Attentional Networks in the Human Brain in Health and Disease: Evidence from Intracerebral and MEG Recordings | 2017 |
| 284 | EPILIPRO | Elucidating the role of Arid1a in adult liver | 2016 |
| 285 | minimal-phagocyte | Reconstitution of the basic molecular mechanism of phagocytosis – a bottom-up synthetic biology approach | 2016 |
| 286 | FORECAST | Fluorescence lifetime optical biopsy system | 2017 |
| 287 | IFNBetaMito | Role of IFN-β in mitochondrial homeostasis and impact on Parkinson Disease | 2016 |
| 288 | BIASTRESS | Neural mechanisms of cognitive bias and its role in the triggering of the stress response in zebrafish | 2016 |
| 289 | MCNANO | “Multi-component nanoparticles as bimodal contrast agents for MRI and optical detection of tumors and for targeted photodynamic therapy” | 2016 |
| 290 | MCANALSMSCA2015 | Receptor signalling in space and time - Gaining high-resolution information of the temporal and spatial control of G protein-coupled receptor signalling. | 2018 |
| 291 | ENDYVE | ENgineering DYnamic ViscoElasticity to study cell response | 2016 |
| 292 | Cleanup-MOFs | Decontamination of emerging pollutant using porous Metal-Organic Frameworks (MOFs) and silica-MOFs composites | 2016 |
| 293 | INTO | Inorganic therapeutic nanoparticles for osteoporosis | 2016 |
| 294 | CaLiAT | A novel pathway for generation of building blocks for antibiotic biosynthesis | 2016 |
| 295 | MolecularEVOLUTION | Molecular Evolution of the Primary Structure of Single Chain Polymer Nanoparticles via Dynamic Covalent Chemistry | 2016 |
| 296 | PepPtNPAntiCan | Peptide Coated Platinum Nanoparticles as Antitumor Agents | 2016 |
| 297 | ESTIMABLeNANO | External Stimuli Triggered Self-assembly of Dynamic Nanomaterials | 2016 |
| 298 | PACEMech | The structure and molecular mechanism of transport proteins within the PACE family of multidrug efflux pumps | 2017 |
| 299 | PMOHR | Probabilistic modelling of electronic health records | 2016 |
| 300 | RAMSES | Aryl amide metallofoldamersas selective saccharide sensors | 2016 |
| 301 | NanoCap | Sustainable Polypeptide Nanoparticle Platform for Drug Delivery | 2016 |
| 302 | ADHERE | Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy | 2016 |
| 303 | DrugCrops | Drought discovery to improve drought tolerance in crops | 2017 |
| 304 | Tribocharge | Control of Triboelectricity from Micro to Macro as a Principle ofSticking, Particulate Contamination and ESD Prevention of Micromachines | 2016 |
| 305 | THERAGEL | Development of a chemotherapeutic gel for glioblastoma multiforme treatment | 2016 |
| 306 | HeartAtaK | Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel | 2016 |
| 307 | CAMEOS | Cardiac micro-engineered tissue for high-throughput screening | 2016 |
| 308 | EHT-CaMKII | CaMKII over stimulation in engineered heart tissues (EHTs) made from human induced pluripotent stem cells (hiPSCs): a parameter involved in the immaturity of hiPSC EHTs cardiomyocytes? | 2016 |
| 309 | AIMMS STAR-PLUS | Scientific Top Training in Antimicrobial Research | 2016 |
| 310 | DesignerAntibiotics | Towards the prevention of aminoglycoside antibiotic-related deafness | 2017 |
| 311 | MRCKa in cancer | Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa | 2016 |
| 312 | ChroMe | Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living | 2016 |
| 313 | NORVAS | Therapeutic and Biomarker Potential of long non-coding RNAs in Vascular Disease | 2016 |
| 314 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 315 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 316 | BOOST | Biomimetic trick to re-balance Osteblast-Osteoclast loop in osteoporoSis treatment: a Topological and materials driven approach | 2016 |
| 317 | Tolerome | Evolution of antibiotic tolerance in the 'wild': A quantitative approach | 2016 |
| 318 | EvoStruc | The physics of antibiotic resistance evolution in spatially-structured multicellular assemblies | 2016 |
| 319 | SUMOWO | Surface modulation of wounds: heal by inhalants!Novel drug-based treatment for excessive scars and chronic wounds. | 2016 |
| 320 | SUPRABIOTICS | Supramolecular Protective Groups Enabling Antibiotics and Bioimaging | 2016 |
| 321 | PreclinSR | Increasing clinical translation of experimental stroke research: new approaches to systematic review | 2016 |
| 322 | DrugSense | Ribo-regulators that sense trace antibiotics | 2016 |
| 323 | InnateMSDyn | Combining in vivo spectral biphoton imaging and multiparametric cytometry to characterize the dynamics of the innate immune response in a multiple sclerosis mouse model | 2016 |
| 324 | CF_struct | High-Resolution X-ray Structures of Full-Length Cystic Fibrosis Transmembrane Conductance Regulator | 2016 |
| 325 | FLUORODRUGS | Smart Theranostic Agents for the Tumour Microenvironment | 2017 |
| 326 | MBD | Mapping bacterial division in Bacillus subtilis | 2016 |
| 327 | MESO-JBIR-102 | Development of the aza-Prins reaction; synthesis and biological evaluation of JBIR-102 | 2016 |
| 328 | 2MoveMate4Melanoma | A treatment for BRAF inhibitor resistant melanoma | 2016 |
| 329 | ANGIO-IMAGE | ANGIO-tracer for immuno-PET imaging: a stratification and monitoring tool for anti-angiogenesis treatment | 2016 |
| 330 | PET3D | PET Imaging in Drug Design and Development | 2016 |
| 331 | SCoTMOF | Combined Chemo- and Radiotherapies by Controlling the Surface Chemistry of Truncated Metal Organic Framework Nanoparticles | 2016 |
| 332 | RANGER | RANGER: RAdars for loNG distance maritime surveillancE and SaR opeRations | 2016 |
| 333 | InjectCHA | Local delivery of PTH(1-34) from an injectable collagen-hydroxyapatite scaffold for non-invasive treatment of bisphosphonate associated atypical femoral fractures | 2016 |
| 334 | CHIKV-FBDD | Structural investigation into functionality of Chikungunya virus nsP2 in replication complex and screening of small molecules for its inhibition | 2016 |
| 335 | ALERT | Local Training Network on Novel Tailor-Made Antimicrobials and Delivery Strategies From Synthesis towards Clinical Applications | 2016 |
| 336 | ENABLE | Elucidating natural bilayer lipid environments | 2016 |
| 337 | CryoProtect | A new cryoprotectant formulation for the next generation of high throughput screening toxicology tests | 2016 |
| 338 | EpiTarget | Epigenome-targeted therapy for cholangiocarcinoma. | 2017 |
| 339 | MESO_BRAIN | Custom architecturally defined 3D stem cell derived functional human neural networks for transformative progress in neuroscience and medicine | 2016 |
| 340 | TRANSREG | Structural and biochemical studies on the regulation of transcription during elongation | 2016 |
| 341 | VIREX | Mumps VIRus EXploitation of the human adhesion receptor GPR125 | 2016 |
| 342 | iGOLDD | Commercialising MR-HIFU: an Image-Guided Local Drug-Delivery Platform | 2016 |
| 343 | DeCISIoN | Drug CandIdates ScreenINg | 2016 |
| 344 | Tom PIT Studio | Tom PIT Studio - platform for designing information systems | 2016 |
| 345 | USONIPRO | Ultrasonic technology for bioprocess enhancement | 2016 |
| 346 | OPTIMIsE | Commercial feasibility of the Novio-PlainGel: a novel synthetic, reversible thermosensitive, biomimetic hydrogel for organoid-based precision medicine | 2016 |
| 347 | Tamed Cancer | Personalized Cancer Therapy by Model-based Optimal Robust Control Algorithm | 2016 |
| 348 | STEM-BCPC | Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer | 2016 |
| 349 | PCFENCM | Pan-cancer functional evaluation of non-coding DNA mutations | 2017 |
| 350 | Miniature Robots | Commercialisation of new miniaturised, automated robots for high throughput training and assessment of dexterity in rats and mice. | 2016 |
| 351 | IMPAX | Inline/Instant Measurement for PhArma eXtrusion | 2016 |
| 352 | TagIt | A Minimal-Tag Bioorthogonal Labelling Approach to Protein Uptake, Traffic and Delivery | 2016 |
| 353 | DrugSynergy | DrugSynergy: A data-driven systems biology approach to optimize drug combination strategies | 2016 |
| 354 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 355 | OCLD | Tracking the Dynamics of Human Metabolism using Spectroscopy-Integrated Liver-on-Chip Microdevices | 2016 |
| 356 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 357 | ULT-MAS-DNP | Dynamic Nuclear Polarization at ultra-fast sample spinning and ultra-low temperature | 2016 |
| 358 | Relieve-Chol | Reprogramming cell identity to develop new therapies against Cholangiopathies | 2016 |
| 359 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 360 | AutoStopS | GluCl as an epileptic seizure autoregulatory Gene therapeutic approach | 2016 |
| 361 | HETSPRESSO | A cartridge based flow chemistry machine for the automated synthesis of N-heterocycles for drug discovery | 2016 |
| 362 | AngioResist | Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist | 2016 |
| 363 | GlioDx | GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients | 2016 |
| 364 | PFKFBLOCK | Translating fundamental insights in endothelial metabolism: PFKFB3 drug discovery and development | 2016 |
| 365 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 366 | NPX-101 | NPX-101 is a portable home device for the treatment of moderate to severe depression, boasting more effective and safer outcomes, based on information deposited and received from the Cloud. | 2016 |
| 367 | FAST-BM | FAST-BM: FibroSelect: delivering A Step-change in Biotherapeutic Manufacturing | 2016 |
| 368 | MY FISH CURE | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2016 |
| 369 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 370 | BETASCREEN | A Unique Pancreatic Human Beta Cells to revolutionize the Diabetes Drug Discovery | 2016 |
| 371 | SEQUOIA-DD | Boosting productivity and performance in drug discovery with SEQUOIA - Semantic Query of Information Assets | 2016 |
| 372 | NanoSil4Cancer | Smart Multifunctional silica-based Nanoparticles for Targeted Therapy | 2016 |
| 373 | PDZnet | Unraveling Principles of PDZ-mediated Cell Signaling | 2016 |
| 374 | INVeST | INdividual Vascular SignaTure: A new machine learning tool to aid personalised management of risk for cardiovascular disease | 2016 |
| 375 | CERAMENT-BC | A novel bone implant with enhanced bone healing capacity | 2016 |
| 376 | VERDI | polyValent mEsopoRous nanosystem for bone DIseases | 2016 |
| 377 | FluoroDendriNostic | Combined fluorinated polymer and poly-L-lysine dendrimer as new potential contrast agents for magnetic resonance imaging 19F | 2016 |
| 378 | TGDNL | Mechanisms of cellular fatty acid homeostasis | 2017 |
| 379 | Protoeukaryotes | Multicompartmental Designs For Protocells | 2016 |
| 380 | SYNOX | Total Synthesis of Biologically Important Pyrrolidinone Natural Products and Analogues Thereof. | 2016 |
| 381 | MESOTAS-SIEVE | Sieving neuronal network communication | 2016 |
| 382 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 383 | SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network | 2016 |
| 384 | BBDiag | Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease | 2017 |
| 385 | MarPipe | Improving the flow in the pipeline of the next generation of marine biodiscovery scientists | 2016 |
| 386 | TRACT | Training in Cancer Mechanisms and Therapeutics | 2016 |
| 387 | PRINT-AID | Multidisciplinary European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality | 2017 |
| 388 | OcuTher | Educational Network in Ocular Drug Delivery and Therapeutics | 2016 |
| 389 | TREATMENT | Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia | 2017 |
| 390 | Train2Target | An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries | 2017 |
| 391 | MMBio | Molecular Tools for Nucleic Acid Manipulation for Biological Intervention | 2017 |
| 392 | BioCapture | Smart capture phases for proteomics, glycomics and biomarker assays | 2016 |
| 393 | CarBon | Controlling Cartilage to Bone Transitions for Improved Treatment of Bone Defects and Osteoarthritis | 2017 |
| 394 | TRAIN | Tribbles Research and Innovation Network | 2016 |
| 395 | GameofGates | Solute carrier proteins as the gates managing chemical access to cells | 2016 |
| 396 | TaGFrag | Stabilising Protein-Protein Interactions: A Target-Guided Fragment-Based Approach | 2016 |
| 397 | RAPID | Rapid Antimicrobial susceptibility testing and phylogenetic Identification | 2016 |
| 398 | chemos | Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials | 2016 |
| 399 | isitFlutter | dIagnoSIs app for regular aTrial arrhytmia like Flutter | 2016 |
| 400 | ANTS | A new technology of microthermal sensing for application in microcalorimetry | 2017 |
| 401 | CENSUS | Cell-Based Models for Neurodegeneration Study and Use in Screening | 2016 |
| 402 | SPARK-TUBE | Spark-Tube Biobanking System (STBS) | 2016 |
| 403 | PhotoMedMet | Towards Novel Inert (Photo-)toxic Ru(II) Polypyridyl Complexes | 2016 |
| 404 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 405 | EMbRACe | Effective Multidrug Cocktails for Cancer | 2016 |
| 406 | HALODRUGSYN | Innovative Strategies towards Halogenated Organic Molecules: From Reaction Design to Application in Drug Synthesis | 2017 |
| 407 | REUSE4MALARIA | Drug Repurposing for Malaria Chemoprotection | 2016 |
| 408 | TERPENECAT | Bridging the gap between supramolecular chemistry and current synthetic challenges: Developing artificial catalysts for the tail-to-head terpene cyclization | 2016 |
| 409 | SupraCarrier | Supramolecular hydrogels as local controlled drug delivery carriers | 2017 |
| 410 | INSPIRED | Targeting IRE1 in disease | 2017 |
| 411 | LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function | 2017 |
| 412 | RAMSES | Reactivity and Assembly of Multifunctional, Stimuli-responsive Encapsulation Structures | 2016 |
| 413 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 414 | PHENOSPACE | Quantifying behavioural phenotype space: chemistry-to-gene screens and combination therapies | 2016 |
| 415 | SWEETBULLETS | Sweet Theranostics in Bitter Infections - Seek and Destroy | 2017 |
| 416 | 3D NEONET | Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics | 2017 |
| 417 | MIMESIS | A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses | 2016 |
| 418 | TOPCAPI | Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients | 2017 |
| 419 | N2B-patch | Nose to Brain Delivery of antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device | 2017 |
| 420 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 421 | OPTOGENERAPY | Optogenetic Protein Therapy for Multiple Sclerosis | 2017 |
| 422 | CUPIDO | Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts | 2017 |
| 423 | METACELL-TM | METAbolism analysis made easy for CELL Translational Medicine | 2016 |
| 424 | GREENBIOCATALYST | NEW GENERATION OF BIOCATALYSTS FOR THE CHEMICAL INDUSTRY | 2016 |
| 425 | Neuroheart | Cardiovascular Molecular Imaging for Personalized Tailored Treatment | 2017 |
| 426 | GUTPEPTIDES | Novel therapeutic approaches to improve gastrointestinal wound healing | 2017 |
| 427 | HP4all | Persistent and Transportable Hyperpolarization for Magnetic Resonance | 2017 |
| 428 | iGBMavatars | Glioblastoma Subtype Avatar models for Target Discovery and Biology | 2017 |
| 429 | TKI resistance | Resistance mechanisms to tyrosine kinase inhibitors in solid tumors | 2016 |
| 430 | GlycoImaging | Imaging and detection of tumor-associated glycan structures on tumor cells | 2017 |
| 431 | CAPICE | Childhood and Adolescence Psychopathology: unravelling the complex etiology by a large Interdisciplinary Collaboration in Europe | 2017 |
| 432 | LISTEN | Liaison in Scientific Training for European auditory Neuroscience | 2016 |
| 433 | LungCARD | Blood test for clinical therapy guidance of non-small cell lung cancer patients | 2017 |
| 434 | QRD | A uniQue platform enabling faster development of treatments for Rare Diseases | 2017 |
| 435 | NOC | Nerve-on-Chips | 2016 |
| 436 | Oncosmart | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2016 |
| 437 | NOTID | Novel treatment of inflammatory diseases | 2016 |
| 438 | ABD | A bioengineered, naturally-derived, sustainable biocide for breaking down organic biofilms formed by drug-resistant bacteria. | 2016 |
| 439 | HPE1 | New high-performance excipients in pharmaceutical industry: an innovative solution for a more efficient and sustainable drug manufacturing process. | 2016 |
| 440 | OVOMATIC | IN-OVO AUTOMATION FOR CANCER DRUG DISCOVERY | 2017 |
| 441 | Fucoderm | An effective, side effect-free topical emollient treatment for atopic dermatitis made from a sustainably procured seaweed extract | 2016 |
| 442 | theEoE | A novel drug candidate for the treatment of Eosinophilic Esophagitis - an innovative solution for a significant unmet medical need | 2016 |
| 443 | 3DCC | Ready-to-use 3D Cell Cultures for early de-risking in drug development | 2016 |
| 444 | TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery | 2017 |
| 445 | anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept | 2017 |
| 446 | EXEDRA | EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials | 2017 |
| 447 | TISuMR | Integrated Tissue Slice Culture and NMR Metabolomics – A Novel Approach Towards SystemicUnderstanding of Liver Function And Disease | 2017 |
| 448 | Mini Brains | Cerebral organoids: human mini brains in a dish open up new possibilities for drug development in neurodegenerative and developmental diseases | 2017 |
| 449 | ALFA | Advanced Low Flying Aircrafts Detection and Tracking | 2017 |
| 450 | MUSCLEGUY | A novel muscle disorders 3D in vitro system for drug screening and validation. | 2016 |
| 451 | Laser-Bioprint | Laser-Based Bioprinter | 2016 |
| 452 | miRCaP | Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy | 2016 |
| 453 | DAMOC | Diabetes Approach by Multi-Organ-on-a-Chip | 2017 |
| 454 | Ultimate | The best drug discovery platform | 2016 |
| 455 | MedEye | Accelerated market launch of MedEye, a plug-and-play medication safety solution | 2017 |
| 456 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
| 457 | Halo | Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets | 2017 |
| 458 | VAHVISTUS | Integrative development of smart drug-vector nanostructures for adaptive delivery to target cells | 2017 |
| 459 | MagnaPharm | Magnetic Control of Polymorphism in Pharmaceutical Compounds | 2017 |
| 460 | One-Flow | Catalyst Cascade Reactions in ‘One-Flow’ within a Compartmentalized, Green-Solvent ‘Digital Synthesis Machinery’ – End-to-End Green Process Design for Pharmaceuticals | 2017 |
| 461 | ArrestAD | 3-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration | 2017 |
| 462 | AutoLiqHand | A Compact and Automated Liquid Handling Platform for Biomedical Assays | 2017 |
| 463 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 464 | BioREAD | BioREAD; a Continuous Barrier Quality Monitoring System for Organs-on-Chip | 2017 |
| 465 | FAST-bact | A novel fast test for antibiotic susceptibility testing for Gram positive and Gram negative bacteria | 2016 |
| 466 | SMILE | Synchrotron Miniaturization enabling Innovative Laboratory Equipment in soft x-ray tomography. | 2017 |
| 467 | FANCODRUG | Reactivation of the Fanconi anemia-BRCA pathway in cells carrying patient-derived missense mutations: finding a drug to cure Fanconi anemia | 2017 |
| 468 | MYCONEUTROPHILS | Elucidating the involvement of neutrophils in the pathogenesis of tuberculosis using a zebrafish model | 2017 |
| 469 | MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer | 2017 |
| 470 | NinZA | Theranostic molecular zipper based switchable nanomedicine for overcoming drug resistance | 2017 |
| 471 | MIX-Effectors | T6SS MIX-effectors: secretion, activities and use as antibacterial treatment | 2017 |
| 472 | BETASCREEN | Validation of an in vivo translational medicine approach for the treatment of diabetes and diabetes complications | 2017 |
| 473 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 474 | NEW-AGE | A next-generation platform for catalysing pre-clinical development of drugs against Alzheimer’s and other degenerative diseases of old-age | 2017 |
| 475 | CureTheCloves | PIK3CA inhibition in patients with the CLOVES syndrome | 2017 |
| 476 | NeuronAgeScreen | A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders | 2017 |
| 477 | Bronchomycn | First in class epithelial Barrier-enhancing medicine for respiratory diseases | 2017 |
| 478 | B-On-Chip | The first compact and easy-to-use microreactor device for Body-On-Chip experiments. | 2017 |
| 479 | RELEASE | Nanofiber based drug delivery for surgical therapy of adult and paediatric solid tumours | 2017 |
| 480 | CHEMMINE | Chemical proteome mining for functional annotation of disease relevant proteins | 2017 |
| 481 | AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes | 2016 |
| 482 | Renaparin | Improving kidney transplantation outcome with Renaparin® for patients with End-Stage Renal Disease by attenuating graft ischemia reperfusion injury | 2017 |
| 483 | Simecos | Novel Arthritis Treatment with focus on natural Chitin Oligosaccharides | 2017 |
| 484 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 485 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 486 | SULIPRO | A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need | 2017 |
| 487 | CBIT | Customisable Bioink Technology Platform | 2017 |
| 488 | COEXIST | Confined, Optically Enhanced, X-ray Imaging Source for Tomography | 2017 |
| 489 | Targeting TopoII | Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward therational design of novel anticancer drugs | 2017 |
| 490 | Stress Imaging | Nanoscale Stress Imaging with Imperfect Diamonds | 2017 |
| 491 | TRPLigDrugConj | TRPV1-targeted ligand-drug conjugates to treat prostate cancer | 2017 |
| 492 | BioMPCat | Bioorthogonal Metal-Peptide Catalysis | 2017 |
| 493 | metabolicomp | Computational dynamics studies of drug metabolism by P450 enzymes | 2017 |
| 494 | ODR | A ubiquitous system for disrupting how Western blot imaging and data processing is carried for clinical analysis | 2017 |
| 495 | PolySolv | Polymer Solvation with COSMO-RS | 2017 |
| 496 | AutoMonoDroplet | Development of a commercially-viable system for the automatic generation of high-throughput well-defined microdroplets | 2017 |
| 497 | EPI-Centrd | Epilepsy Controlled with Electronic Neurotransmitter Delivery | 2017 |
| 498 | FLUDD | Late Stage Fluorination and its Applications to Drug Discovery | 2017 |
| 499 | ONCOmetENHANCERS | Elucidating the Role of Enhancer Methylation Variation in Cancer and Developing Enhancer-based Markers and Targets for Precision Medicine | 2017 |
| 500 | 3DPD | PhD position in commercial environment: cancer immunotherapy drug screening in 3D | 2017 |
| 501 | Cloud-HTMD | A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT MOLECULAR DYNAMICS | 2017 |
| 502 | CoALIVE | Coenzyme A – Launch of In Vivo Experiments | 2017 |
| 503 | RapidDiag | Development of a compatible nanoparticle based rapid and sensitive diagnostic platform for microbial infections | 2017 |
| 504 | TheranOMICS | Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer | 2017 |
| 505 | AqPDRA | Industrial research into the properties of molecular capsules in commercially relevant media | 2017 |
| 506 | CMI2T IA | Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 |
| 507 | OMICS | Origami-based Microfluidic Interface for Cell Signalling | 2017 |
| 508 | Schizo-EPICOG | Inflammatory processes underlying cognitive deficits in schizophrenia: epigenetic mechanisms and pharmacological regulation | 2018 |
| 509 | ACTPD | Streamlined Functionalisation of Nitrogen-containing Molecules by Palladium-catalysed C-H Activation | 2017 |
| 510 | BRAINHIB | Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation | 2018 |
| 511 | TSPO METALLODRUGS | Novel, highly effective and selective anticancer metallodrugs | 2018 |
| 512 | ColoFILM | Multifunctional polymeric film-based drug delivery system for oral anti-TNF-alpha-based inflammatory bowel disease therapy | 2017 |
| 513 | PGXOME | A pharmacogenomic exploration of adverse drug reactions in epilepsy | 2017 |
| 514 | RHOMBOSMALPS | Enabling malaria rhomboid proteases as drug targets: usage of molecular cookie cutters to shape novel activity assays and inhibitors. | 2017 |
| 515 | PaCDoC | Electric field driven propulsion and collective dynamics of homogeneous and patchy colloidal capsules. | 2017 |
| 516 | EPOFFSPRING | Epigenetic mechanisms underlying the influence of paternal drug experience on offspring behavior | 2017 |
| 517 | PhySense | Physarum Sensor: Biosensor for Citizen Scientists | 2017 |
| 518 | BIOSPEC | BIOphotonic SPECialists for Novel Raman Spectrometer Development | 2017 |
| 519 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 520 | ACTIVEMOTION3D | Experimental Study of Three-dimensional Dynamics of Active Particles | 2017 |
| 521 | GOLDENSENS | Intrinsically chiral gold nanoclusters as enantiodiscriminating sensors for methamphetamines. | 2017 |
| 522 | TRIBBLES | Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma | 2018 |
| 523 | SHAPPI | Scaffold hybridization approach targeting PPIs | 2017 |
| 524 | DualFun | Dual Function Polymer Materials for Blood Contacting Applications | 2017 |
| 525 | GLIOMA | Targeting Glioblastoma using Combinatorial Therapeutic Nanovaccine | 2017 |
| 526 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 527 | FRAGMENTOME | FRAGMENT screening from advanced-sampling molecular dynamics simulations on a proteOME scale. | 2017 |
| 528 | DNCSS | Decoding neural circuits controlling sleep drive and sedation | 2018 |
| 529 | GlimS | Patient-specific tumour growth model for quantification of mechanical 'markers' in malignant gliomas: Implications for treatment outcomes. | 2017 |
| 530 | PIONEER | Peri-Ocularly Navigated Exteroceptive Snake Robot for Novel Retinal Interventions | 2017 |
| 531 | RAMP | RAtionalising Membrane Protein crystallisation | 2017 |
| 532 | NMRNTECH | NMR-based Sensor Technology at Nanoscale | 2017 |
| 533 | TOXANOID | Pharmacological safety testing in human adult stem cell-derived organoids | 2017 |
| 534 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 |
| 535 | HIVGAYM | Analysing the migration choices of HIV-positive gay men in England and France | 2018 |
| 536 | RNAatHD | Development of a high-resolution method to monitor structural changes of regulatory RNAs and therapeutic oligo-nucleotides directly in-cell. | 2017 |
| 537 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 538 | MuSCel Genome | Muscle Specific C. elegans Genome in health and disease: finding novel factors in 3D organization | 2017 |
| 539 | ESSEVOL | Adapting to Change: Experimental Evolution of Environmental Sensing Systems in Bacteria | 2017 |
| 540 | JTIM | Biodegradable Water-Soluble Cylindrical Block Copolymer Micelles and their Applications in Nanomedicine | 2018 |
| 541 | SAMNets | Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network | 2017 |
| 542 | UCOC | Understanding the Commitment in Organized Crime | 2018 |
| 543 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
| 544 | MOOAC | Multi-compartmental Organ-on-a-Chip | 2018 |
| 545 | PRISM | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 | 2016 |
| 546 | PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 | 2016 |
| 547 | PHAGO | Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 | 2016 |
| 548 | HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 | 2017 |
| 549 | TransQST | Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 | 2017 |
| 550 | IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 |
| 551 | PlasmoCycle | DNA dynamics in the unusual cell cycle of the malaria parasite Plasmodium falciparum | 2017 |
| 552 | DUALITY | An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors | 2018 |
| 553 | IDRAM | The role of amphidial drug uptake in the mode of action and resistance to ivermectin in nematodes of livestock | 2017 |
| 554 | MalariaEgress | Role of perforin-like proteins and phospholipases in malaria parasite egress | 2018 |
| 555 | BonE-GraphT | Ti-Graphene Bone Tissue Template Engineering | 2017 |
| 556 | Tau Seeding | Identification and validation of human proteins that control tau seeding in cell-based and in vivo models | 2017 |
| 557 | NARCOREADER | Novel electrochemical strategies for rapid, on-site multiscreening of illicit drugs | 2017 |
| 558 | DYNAMO | Structural Dynamics of Membrane Receptors at native-like conditions | 2018 |
| 559 | GeneVision | Developing a cure for retinitis pigmentosa due to Usher syndrome | 2017 |
| 560 | LABEL-DIOX | Late-stage catalytic carboxylation techniques with labelled carbon dioxide: new opportunities for radiolabelling | 2017 |
| 561 | DNA ORIGAMI MOTORS | Constructing and powering nanoscale DNA origami motors | 2017 |
| 562 | IndiviStat | Individualizing statin therapy by using a systems pharmacology decision support algorithm | 2017 |
| 563 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 564 | PHRD | The development of Personalised Host Response Diagnostic kit | 2017 |
| 565 | ACOUSEQ | Acoustics for Next Generation Sequencing | 2017 |
| 566 | Motivageing | Motivation–cognition interaction in healthy ageing and Parkinson’s disease | 2018 |
| 567 | QUSMI | Translating quantum sensing into cost-effective molecular imaging | 2017 |
| 568 | ZECARDIO | Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo | 2017 |
| 569 | BEAT | The functional interaction of EGFR and beta-catenin signalling in colorectal cancer: Genetics, mechanisms, and therapeutic potential. | 2017 |
| 570 | UPMab | Unlocking the Potential of deep-sea Marine Algae and Bacteria | 2017 |
| 571 | MARISA | Maritime Integrated Surveillance Awareness | 2017 |
| 572 | NEUROMODEL | Statistical Modelling for relating multimodal neuroimaging to clinical outcomes in order to predict patient response to depression therapy. | 2017 |
| 573 | DUBs26S | Role of a novel proteasome-associated DUB – A boon for therapeutics | 2017 |
| 574 | CTCapture_2.0 | Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients | 2017 |
| 575 | Vis-a-Vis | Collective Infectious Units and the Social Evolution of Viruses | 2017 |
| 576 | NanoMOFdeli | Design of NanoMOFs Capsules for Drug Delivery and Bioimaging. | 2017 |
| 577 | VIPS | Venomics In Predator-prey Systems | 2017 |
| 578 | BLMs 4 TB | Beta-lactams for Tuberculosis Treatment | 2018 |
| 579 | NeMatrix | Nematode-based screening technology for next-generation drug discovery | 2017 |
| 580 | CHIMERA | A novel instrument to identify chiral molecules for pharmaceutics and bio-chemistry. | 2017 |
| 581 | NGN-PET | Modelling Neuron-Glia Networks into a drug discovery platform for Pain Efficacious Treatments - Sofia ref.: 116072 | 2017 |
| 582 | altEJrepair | Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy | 2017 |
| 583 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 584 | GenEdiDS | Rescuing Cognitive Deficits in Neurodevelopmental Disorders by Gene Editing in Brain Development: the Case of Down Syndrome | 2017 |
| 585 | ECM_INK | Cells-self Extracellular Matrices-based Bioinks to create accurate 3D diseased skin tissue models | 2017 |
| 586 | DeShield | Hide and Seek with Cancer Drugs | 2017 |
| 587 | MwHresEP | Multi-well High-resolution Electrophysiology Platform | 2017 |
| 588 | MEDAS | MedAS: a Machine learning enabled Clinical Decision Support System to prevent prescription errors and improve patient safety | 2017 |
| 589 | FRAGMENT2DRUG | Jigsaw puzzles at atomic resolution: Computational design of GPCR drugs from fragments | 2017 |
| 590 | BUNGEE | Directed crop breeding using jumping genes | 2017 |
| 591 | ACTICELL | Precision confiner for mechanical cell activation | 2017 |
| 592 | Anapphylaxis | The first Integrated m-Health solution for anaphylaxis management. | 2017 |
| 593 | Genome Biologics | Reducing the cost and increasing the speed of preclinical research in the pharmaceutical industry | 2017 |
| 594 | iSAFE | iSAFE Internet Safety Awareness for European primary school children | 2017 |
| 595 | SynVaccine | Rational Design and Construction of Viral Based Products | 2017 |
| 596 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 597 | cis-CONTROL | Decoding and controlling cell-state switching: A bottom-up approach based on enhancer logic | 2017 |
| 598 | PROMINENT | Personalised Medicine in Diabetic Chronic Disease Management | 2017 |
| 599 | Castor EDC | Castor EDC: Unlocking the Potential of Data in Biomedical Research | 2017 |
| 600 | NO-ESKAPE | Addressing Antibiotic Resistance: New Strategies for Overcoming the ESKAPE Pathogens | 2017 |
| 601 | Cellphmed | Accurate cell signatures for the advancement of personalized medicine | 2017 |
| 602 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
| 603 | ChAMPioN | Game-changing Precision Medicine for Curing All Myeloproliferative Neoplasms | 2018 |
| 604 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 605 | iEBDD | A Software Interface for Interactive Ensemble-Based Drug Design | 2017 |
| 606 | ImmortaSTEM | ImmortaSTEM: Transient Immortalisation for Patient Stem Cell Expansion and Therapeutic Application | 2017 |
| 607 | NOVITREP | Novel viral therapy through targeting DNA repair | 2017 |
| 608 | RHYP | A new hope for early gonarthrosis treatment using a biotechnological therapeutic drug to regenerate cartilage by intra-articular knee injection | 2017 |
| 609 | PeptIn | employing protein aggregation as an antibacterial design strategy | 2017 |
| 610 | BigData Heart | Big Data 4 Better Hearts - Sofia ref.: 116074 | 2017 |
| 611 | MedicSen | A new innovative method for diabetes treatment, the artificial pancreas system | 2017 |
| 612 | MetaTox-HS | Advanced Solutions for High Sensitivity Metabolism and Toxicity Assays | 2017 |
| 613 | NanoBeat | Developing Smart 3D Scaffolds based on Conductive Polymers and Carbon Nanotubes for Cardiac Tissue Engineering | 2018 |
| 614 | ORCHID | Organ on Chip in Development | 2017 |
| 615 | STOPCa | The cryptic path of tumor-microenvironment interactions in prostate cancer | 2017 |
| 616 | ThermalMR | Thermal Magnetic Resonance: A New Instrument to Define the Role of Temperature in Biological Systems and Disease for Diagnosis and Therapy | 2018 |
| 617 | ULTIMATE | The best online drug discovery platform, Building the Ultimate chemical database for drug discovery | 2017 |
| 618 | f-ex | f-block hydrocarbon interactions: exploration; exploitation | 2017 |
| 619 | CodeSphere | CodeSphere - Discovering Therapeutic Nanoparticles by Molecular Encoding | 2017 |
| 620 | SYN1002 | A New Therapeutic Option to Protect Central Nervous System against Acute Ischemic Stroke | 2017 |
| 621 | CADENCE | Catalytic Dual-Function Devices Against Cancer | 2017 |
| 622 | DoDyNet | Double Dynamics for design of new responsive polymer networks and gels | 2017 |
| 623 | EuroNeurotrophin | A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation | 2018 |
| 624 | iDESIGN | Delivering Better Starting Points for Drug Discovery: New Compound Libraries Driven By Intelligent Design | 2018 |
| 625 | IT-DED3 | Integrated Training in Dry Eye Disease Drug Development (IT-DED3) | 2018 |
| 626 | MACULA2 | Commercialising a novel diagnostic panel for patient stratification in Age-related MACULAr Degeneration | 2017 |
| 627 | NeuroQure | Neuroprotective human antibodies to the flexible tail of the prion protein | 2017 |
| 628 | PhD4GlycoDrug | Multidisciplinary European Joint Doctorate in the Design and Development of Glyco Drugs | 2017 |
| 629 | PurinesDX | Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases. | 2017 |
| 630 | SAGAPROPLUS | A Unique Herbal Product for the Symptomatic Treatment of Over Active Bladder | 2017 |
| 631 | STARDUST | in vivo optogeneticS, elecTrophysiology and phArmacology with an ultRasonically-powered DUST for Parkinson's Disease | 2017 |
| 632 | SUDOCHIP | New antiperspirant efficacy evaluation techniques based on a disruptive microfluidic technology | 2017 |
| 633 | EVICARE | Extracellular Vesicle-Inspired CArdiac Repair | 2017 |
| 634 | VisTrans | Visualising transport dynamics of transmembrane pumps | 2017 |
| 635 | CARTNET | Combatting Antimicrobial Resistance Training Network | 2018 |
| 636 | transMed | Educating the next generation of scientists in translational medicine: Focus on eye diseases | 2017 |
| 637 | CONTRA | Computational ONcology TRaining Alliance | 2018 |
| 638 | GLIOTRAIN | Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | 2017 |
| 639 | CellPrintArray | CellPrintArray – on-demand nano-scale printing of live cells and compounds for miniaturized cell screening applications | 2017 |
| 640 | ENTRANCE | Developing the iTOP kit: Empowering scientists with efficient intracellular delivery of biologicals in hard-to-manipulate cell types | 2017 |
| 641 | AptaCheck | Bioelectronic lab-on-a-chip for point-of-care detection of infectious agents | 2017 |
| 642 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 643 | noRAG-TOR | Rag-independent regulation of mTOR by Amino Acids | 2018 |
| 644 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 645 | TarMyc | Targeting the Oncogenic Function of Myc in vivo | 2018 |
| 646 | VIRO-FLOW | Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors | 2017 |
| 647 | TRIPLECON | Triple negative breast cancer control through synergistic inhibition of EGFR and CDK9 signaling | 2017 |
| 648 | eTRANSAFE | Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management | 2017 |
| 649 | ALGOA | Novel algorithm for treatment planning of patients with osteoarthritis | 2018 |
| 650 | BugTheDrug | Predicting the effects of gut microbiota and diet on an individual’s drug response and safety | 2018 |
| 651 | FAITh | Fighting Anxiety with Importin-based Therapeutics | 2017 |
| 652 | LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis | 2017 |
| 653 | ORBIS | Open Research Biopharmaceutical Internships Support | 2018 |
| 654 | INVICTUS | IN VItro Cavitation Through UltraSound | 2017 |
| 655 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 656 | LIGHTOPLEX | Light triggered non-invasive gene delivery through lipopolyplexes | 2018 |
| 657 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 658 | SONGBIRD | SOphisticated 3D cell culture scaffolds for Next Generation Barrier-on-chip In vitro moDels | 2018 |
| 659 | BONDS | Bilayered ON-Demand Scaffolds: On-Demand Delivery from induced Pluripotent Stem Cell Derived Scaffolds for Diabetic Foot Ulcers | 2017 |
| 660 | ERACHRON | Eradicating Chronic Infections | 2018 |
| 661 | PROMETHEUS | Flame nanoengineering for antibacterial medical devices | 2018 |
| 662 | SilkFUSION | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research | 2017 |
| 663 | CfC | Carrier for Cure: tailored combination drug delivery solutions for oncology | 2017 |
| 664 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 665 | CISTEM | Heart On chip based on induced pluripotent Stem cell Technology for personalized Medicine | 2018 |
| 666 | DIDO-MS | Commercialization of a first in class multiple sclerosis drug | 2018 |
| 667 | NarcoScan | NarcoScan pocket-sized and affordable narcotics screener: making drug detection on the streets as common as catching drunk drivers | 2017 |
| 668 | BIOSIM | Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence | 2017 |
| 669 | EDIReX | EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts | 2018 |
| 670 | SAVEBRAIN | Proof of principle for a first in class neuroprotective therapy in stroke and other acute neurodegenerative conditions | 2018 |
| 671 | New Chol | Development of New therapies against cholangiopathies. | 2017 |
| 672 | EXOGENESIS | Syntenin-phosphatidic acid interaction in exosome biogenesis and cell-cell communication: a structure-function based approach | 2018 |
| 673 | CLIMB | Development of a Cavity Supported Lipid Membranes Biomimetic drug permeability models (CLIMB) | 2018 |
| 674 | UshTher | Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB | 2018 |
| 675 | MCDS-Therapy | Repurposing of carbamazepine for treatment of skeletal dysplasia | 2017 |
| 676 | HIT-CF | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | 2018 |
| 677 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 678 | OligoGpivotalCF | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | 2018 |
| 679 | LIMA | Liquid biopsies and Imaging for improved cancer care | 2018 |
| 680 | iMove | Translating rewards to eye movements | 2018 |
| 681 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 682 | DIAMONDCOR | A molecular approach to treat diabetes mellitus onset dependent coronaropathy | 2018 |
| 683 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 684 | ToMeTuM | Towards the Understanding a Metal-Tumour-Metabolism | 2018 |
| 685 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 686 | INTERCELLMED | SENSING CELL-CELL INTERACTION HETEROGENEITY IN 3D TUMOR MODELS:TOWARDS PRECISION MEDICINE | 2018 |
| 687 | MASTFAST | Rapid production of HUMAN MAST CELLS | 2017 |
| 688 | REPO-TRIAL | An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes | 2018 |
| 689 | STriTuVaD | In Silico Trial for Tuberculosis Vaccine Development | 2018 |
| 690 | InSilc | InSilc: In-silico trials for drug-eluting BVS design, development and evaluation | 2017 |
| 691 | REMIX | Regenerative Medicine Innovation Crossing - Research and Innovation Staff Exchange inRegenerative Medicine | 2017 |
| 692 | Nano-OligoMed | Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications | 2017 |
| 693 | D_Bug | Innovative Antibiotics to target drug-resistant microbes | 2017 |
| 694 | Drug the bug | Identification of novel inhibitors to prevent microbial production of pro-diabetic metabolites | 2017 |
| 695 | INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer | 2017 |
| 696 | N-IF | The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies | 2017 |
| 697 | BioAhead | BioAhead – an innovative optimization algorithm for amino acid chain analytics | 2017 |
| 698 | NANOSTORM | Design of Nanomaterials for Targeted Therapies Guided by Super Resolution Imaging | 2018 |
| 699 | NovAnI | Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies | 2018 |
| 700 | CTC-MAL | Isolation of rare circulating tumor cells | 2018 |
| 701 | CMTaaRS | Defective protein translation as a pathogenic mechanism of peripheral neuropathy | 2018 |
| 702 | SULFOSOL | Sulfur-based solutions for the selective functionalization of organic substrates | 2018 |
| 703 | LACOPAROM | Lewis acid promoted copper catalysis to functionalise and dearomatise arenes | 2018 |
| 704 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 705 | MicroBone | Novel 3D platforms to engineer bone microtissues for in vitro disease models | 2018 |
| 706 | DrBox | eHealth platform to assess patient clinical progress due to prescribed medication | 2018 |
| 707 | oWBI | Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery | 2018 |
| 708 | PulseHaler | PulseHaler: Improving the Lives of COPD Patients | 2017 |
| 709 | DifMATRIX | Ground breaking 3D cell culture platform to eliminate animal testing in pharmaceuticals | 2018 |
| 710 | BTech | Novel human neurodegenerative disease specific 3D cell-models with applications in drug development and toxicity testing | 2018 |
| 711 | PREDICT | PREDICT | 2018 |
| 712 | GREENSENSE | Sustainable, Wireless, Autonomous Nanocellulose-based Quantitative DoA Biosensing Platform | 2018 |
| 713 | ID-EPTRI | Infradev - European Paediatric Translational Research Infrastructure | 2018 |
| 714 | REMATCH | Image-based analysis for drug discovery and repurposing | 2018 |
| 715 | UTERUS | Unravelling gamma delta T cell emergence and responses in the uterus | 2018 |
| 716 | NovInDXS | Development of novel inhibitors of the anti-infective target DXS using dynamic combinatorial chemistry (DCC) | 2018 |
| 717 | ProTeAN | Production and Testing of humAn-derived Neurons and brain organoids: advanced model probing in neurodevelopmental disorders | 2018 |
| 718 | 3DProSeed | 3DProSeed: the first ready-to-use, pre-assembled, hydrogel microtiter plate for 3D cell culturess | 2018 |
| 719 | BCPPlus | New directions in bicyclopentane research | 2018 |
| 720 | ASYMFLU | Asymmetric Organocatalytic Fluorination with fluoride salts | 2018 |
| 721 | CF3-DIAZOMETHYLATOR | Photocatalytic C–H Bond CF3-diazomethylation | 2018 |
| 722 | MulArEffect | Theoretical description of the multifaceted aromaticity and resonance effects in the ground- and excited-state molecular systems | 2018 |
| 723 | POLYTHEA | Design and photo-optimization of Photosensitizer for Human Health and Food security applications or “how light can save lives” | 2018 |
| 724 | INSPIRE | Instrument Shape Sensing for Minimally Invasive Interventions | 2018 |
| 725 | CC-LEGO | CC-LEGO: robust protein blocks to build cages and layers | 2018 |
| 726 | ZIDOMS | Using Zebrafish as a novel tool to Improve the Diagnosis and Outcome of Marfan Syndrome | 2018 |
| 727 | CaLecLig | Calcium-dependent Lectins in Human Pathogenic Infections: From Atomistic Understanding to Ligand Design | 2018 |
| 728 | SoftNanoHybrid | Polymer-Nanoparticle co-assembly for drug targeting and release kinetics: Investigation on Structure, Morphology, Responsiveness, and Nanoparticle distribution | 2018 |
| 729 | INTERGLU | Dissecting mGlu5 receptor internalization pathways using genetic and pharmacological tools | 2018 |
| 730 | FINDER | FINDER: FIghtiNg DEngue viRus, a novel strategy for the development of fully protective antiviralsthat act by disrupting the DENV NS3/NS5 interaction | 2018 |
| 731 | ChromaFish | Chromatographic micro-column development for pharmaceutical applications in zebraFish | 2018 |
| 732 | AutoDropProd | Development of a commercially-viable system for the automatic generation of high-throughput well defined single and double microdroplets | 2018 |
| 733 | CellularNanoMachines | Development of Stimuli-Responsive Nanoparticle-carrying T lymphocytes in the Fight against Cancer | 2019 |
| 734 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 735 | CheSSTaG | Chemotactic Super-Selective Targeting of Gliomas | 2018 |
| 736 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 737 | EATing more | Enhancing Engulfment of Apoptotic cells: basic biology to Therapy | 2018 |
| 738 | SaRNAReg | Staphylococcus aureus sRNA targetomes and regulatory networks involved in fast adaptive responses: structure, mechanisms and dynamics | 2018 |
| 739 | TRECEPTORS | Transport and Receptor Mechanisms of Human Solute Carriers | 2018 |
| 740 | Reprogram-Diabetes | In vivo drug discovery for cellular reprogramming to β-cells – towards a future regenerative therapy for diabetes | 2018 |
| 741 | EScORIAL | Emerging Simplex ORigins In ALS | 2018 |
| 742 | MicroC | Agent-Based Modelling of Gene Networks to model clonal selection in the tumour microenvironment and predict therapeutic resistance | 2018 |
| 743 | SEXinMALARIA | Sex in malaria parasites – from basic biology to targets for transmission blocking interventions. | 2018 |
| 744 | ReMedPsy | Re-emerging Magic Molecules: The Medicalization of Psychedelics in the United States | 2018 |
| 745 | Mtb CoaBC | CoaBC from the Coenzyme A pathway of Mycobacterium tuberculosis as an antimicrobial drug target | 2018 |
| 746 | EXCITATOR | Active probing of brain excitability by electrical micro-stimulations for drug discovery | 2018 |
| 747 | NEOTERP | Development of novel synthetic strategies for the synthesis of bioactive meroterpenoids | 2018 |
| 748 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 749 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 750 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
| 751 | NaKStruc | Structural studies of Na,K-ATPase isoforms and mutants | 2018 |
| 752 | NanoFEITH | Nanoparticles for Fluorescence-Enhanced Imaging and Therapy of Breast Cancer | 2018 |
| 753 | MECH-LoC | Mechanically tuned Lung-on-a-Chip device to model pathology and drug screening for lung disease | 2018 |
| 754 | NEUROTARGET | Treatment of traumatic brain injury using dye-loaded polymeric nanoparticles | 2018 |
| 755 | WolAntiS | Using antisense inhibition to understand Wolbachia symbiosis and antiviral protection | 2019 |
| 756 | rSAMs-NANO | Nanoparticles with switchable shells for virus sensing and inhibition | 2018 |
| 757 | NMRSIGN | NMR insights on the soluble Guanylyl Cyclase conformational dynamics to illuminate the SIGNaling pathway | 2018 |
| 758 | PREMEDiCARE | PREcision MEDicine with induced pluripotent stem cells for Cardiac Arrhythmias Risk Evaluation | 2018 |
| 759 | PHANTOM | Phenotypic screening the host antimicrobial responses towards the eradication of Mycobacterium tubercuosis | 2018 |
| 760 | TCDL | Topological Colloidal Double Layers | 2018 |
| 761 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 762 | MTOAC | Multi-compartmental Tumor-on-a-Chip | 2018 |
| 763 | PHOTO ORGANO-Ir CAT | Photochemical cascade reactions by merging organo- and iridium catalysis: A stereocontrolled entry to molecular complexity. | 2018 |
| 764 | FATarget | Drugs targets in sympathetic neurons controlling adiposity. | 2019 |
| 765 | EvISC | Infection of the human intestine by enteroviruses: A CRISPR-based screening approach | 2019 |
| 766 | iCHEMGENODRUGS_TB | Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis | 2018 |
| 767 | VitC | Structural studies of the full-length human Vitamin C transporters: unravelling Vitamin C transport across the membrane | 2018 |
| 768 | qMAR | Quantification of the intestinal load of a targeted set of resistance genes to Monitor Antibiotic Resistance in paediatric transplant patients | 2018 |
| 769 | SquaMem | Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study | 2018 |
| 770 | Spectro-Metrics | Advanced Data Mining Procedures Applied to Raman Spectroscopy Investigations of Interactions between Drugs and Cells. | 2018 |
| 771 | PHOTO-FLUOR | Enantioselective Carbon-Fluorine Bond Formation: A Molecular Editing Approach toward Drug Discovery | 2018 |
| 772 | INMARE | Injectable hydrogels for magnetically-activated, remote-controlled drug delivery | 2019 |
| 773 | GlycoPCs | How do Pharmacological Chaperones work? Molecular basis of the actions of glycomimetics on keyglycosidases involved in lysosomal storage disorders | 2018 |
| 774 | simpetmr | Development of quantification procedures for simultaneous PET-MR data for human brain imaging | 2018 |
| 775 | Gut-AnorexiaNervosa | Metagenomics and metabolomics studies of patients with Anorexia Nervosa to identify intestinal microbial mechanisms contributing to pathogenesis | 2018 |
| 776 | NEUROTILES | Bioengineered hippocampal organoids for epilepsy treatment | 2018 |
| 777 | MRI COMIQSUM | MRI COntrast using MIcrobubbles in Quantitative SUsceptibility Mapping | 2018 |
| 778 | DIRECT Therapies | Diabetes Immunoengineering: Redesigning Encapsulated Cell Transplant Therapies | 2018 |
| 779 | RE-IMMUNE | Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer | 2019 |
| 780 | AstroMiRimage | Super-resolution imaging to uncover microRNA control of astrocytes in epilepsy | 2018 |
| 781 | GEMZ | Genetic Epilepsy Models in Zebrafish | 2019 |
| 782 | transLEISHion | A targeted knockout screen for identification of Leishmania membrane transporters required for infection of macrophages | 2018 |
| 783 | IN-3D-CAN | Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies | 2018 |
| 784 | MAGNET-CELLPATCH | Multimodal magnetic cellular-patches with synergistic effects for high performance theranostics | 2019 |
| 785 | GLYMPHARMA | Modulation of the glymphatic system: a novel tool for drug delivery to the central nervous system | 2018 |
| 786 | TANWORM | How do tannins kill parasitic worms? | 2019 |
| 787 | HiMIN | Histone H3.3 oncogenic mutations: a role in genome instability through altered DNA repair and replication fork stability? | 2018 |
| 788 | Neuronetmir | Role of miR-129-5p and Rbfox1 crosstalk in neural network homeostasis | 2018 |
| 789 | NovelKnees | Targeting Subchondral Bone Marrow Lesions, Microdamage and Remodelling using Novel Bisphosphonate-Loaded Delivery Systems to Prevent Post-Traumatic Osteoarthritis after Acute Knee Injury | 2018 |
| 790 | OSTtrans | The Role of OSTα/β as a Bile Acid and Drug Transporter in Obesity-Associated Chronic Liver Disease, Nonalcoholic Fatty Liver Disease | 2018 |
| 791 | HDAC6_GEMM | Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. | 2018 |
| 792 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 793 | NANOBOTS | Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers | 2018 |
| 794 | EyeTREAT | Innovative tool for personalized treatment of patients with neovascular age-macular degeneration: dosage optimization for long term efficacy treatment | 2018 |
| 795 | 2STOP_TBE | Structural Openings to Understand and Prevent Tick Borne Encephalitis | 2018 |
| 796 | PCaProTreat | Multi-omics molecular treatment targets for Prostate Cancer | 2018 |
| 797 | ML Potentials | Constructing Intermolecular Potentials by Combining Physics and Machine Learning | 2018 |
| 798 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
| 799 | TakeupSLaCk | Role and regulation of dendritic cell functions by Solute Carrier Transporters | 2019 |
| 800 | kANNa | Knowledge graph completion using Artificial Neural Networks for Herb-Drug Interaction discovery | 2019 |
| 801 | VECMA | Verified Exascale Computing for Multiscale Applications | 2018 |
| 802 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 803 | THERACAT | Bio-orthogonal catalysis for cancer therapy | 2018 |
| 804 | SympatimmunObesity | Sympathetic and immune mechanisms underlying obesity | 2019 |
| 805 | BIORECAR | Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues | 2018 |
| 806 | SILICOFCM | In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy | 2018 |
| 807 | IMI-PainCare | Improving the care of patients suffering from acute or chronic pain | 2018 |
| 808 | mitozippers | Mitochondrial membrane-targeted compounds for cancer therapy | 2018 |
| 809 | ElectroGene | Electrogenetics – Shaping Electrogenetic Interfaces for Closed-Loop Voltage-Controlled Gene Expression | 2018 |
| 810 | MicroLightProtoCell | Microfluidics-assisted design and construction of light-responsive protocells | 2018 |
| 811 | UBioRec | Development and Testing of a Reference Computational Platform for Understanding BiomolecularRecognition | 2018 |
| 812 | BioNanoMagnets | Capturing the biomineralization of magnetite nanoparticles with magnetotactic bacteria in vivo using microfluidic conditions and synchrotron-based X-ray spectroscopy | 2018 |
| 813 | MAPSYNE | Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks | 2018 |
| 814 | EVO-NANO | Evolvable platform for programmable nanoparticle-based cancer therapies | 2018 |
| 815 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 816 | B2B | Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. | 2018 |
| 817 | VES4US | Extracellular vesicles from a natural source for tailor-made nanomaterials | 2018 |
| 818 | MyoChip | Building a 3D innervated and irrigated muscle on a chip. | 2018 |
| 819 | PHINDaccess | Strengthening Omics data analysis capacities in pathogen-host interaction | 2018 |
| 820 | SENCAN | Senescence therapy for cancer | 2018 |
| 821 | DYNACOTINE | Signal transduction and allosteric modulation of nicotinic acetylcholine receptors:from ion channel electrophysiology to atomic 3D structures | 2019 |
| 822 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 823 | PITBUL | Point-of-Care implementation of TB testing with ultra-fast Local Heating PCR | 2017 |
| 824 | DISCOVER | Death receptor signalling in tumour immune editing | 2018 |
| 825 | BIOCOPY | BIOCOPY: the new biomolecule copying and screening solution for diagnostics and therapeutics | 2018 |
| 826 | SOLUPORE | Solupore® - Enabling the Manufacture of Affordable New Treatments to Cure Cancer | 2018 |
| 827 | HypoSkin | Unique breakthrough ex vivo human skin model to predict efficacy and toxicity of subcutaneous drugs | 2018 |
| 828 | UCRxF | A novel ulcerative colitis treatment - A phase III ready feasibility study | 2018 |
| 829 | SEEVIX Phase-1 | Spidersilk fibers as scaffold for tissue engineering: skin regeneratin and wound healing | 2018 |
| 830 | Lab-on-Skin | Lab-on-Skin: A wearable medical device for improved clinical trial monitoring | 2018 |
| 831 | FasNaGel | NOVEL THERAPEUTIC NANOHYDROGEL FOR ACUTE AND CHRONIC PAIN TREATMENT TARGETED TO THE NERVES FASCIA | 2018 |
| 832 | RheumArth | New drug for the treatment of rheumatoid arthritis | 2018 |
| 833 | TRILLIO | TRILLIO, a porTable pRescription assistant Improving heaLth of Europeans citizens by increasing therapeutic adherence in eLderly people and in patIents affected by chrOnic diseases | 2018 |
| 834 | ReSOLUTE | Research empowerment on solute carriers (ReSOLUTE) | 2018 |
| 835 | PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH) | 2018 |
| 836 | GENBIO | Reducing the cost, time, and ethical burden of preclinical research in the pharmaceutical industry | 2018 |
| 837 | iMOTED | iMOTED Platform Built to improve Clinical Trial outcomes | 2018 |
| 838 | MOOD | Feasibility Study for the introduction into pre-clinical study domain of the first-of-a-kind Multi Organ On Device (MOOD) technology | 2018 |
| 839 | PICARD | Disruptive GPCR Lead Discovery Platform Delivering New and Safer Therapeutics | 2018 |
| 840 | prudenta | Prudenta: Electronic Solution for Safer Drugs | 2018 |
| 841 | KHON2bTREAT | Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market | 2018 |
| 842 | L2L | Leap-to-Lead platform for expanding Drug Discovery beyond its current limits | 2018 |
| 843 | CC-Coupler | Integrated approach for environmentally benign C-C coupling reactions | 2018 |
| 844 | MIN4ALD | Use of MIN-102 for the treatment of children with cerebral ALD | 2018 |
| 845 | CG01 | A novel gene therapy for epilepsy | 2018 |
| 846 | Sea4Pain | Development of a novel analgesic for chronic pain from marine-derived compounds | 2018 |
| 847 | MiCoBion | Microbial Communities in Biomedical and Environmental Areas, and Systems Biology | 2018 |
| 848 | PhagoPROD | GMP manufacturing & GLP diagnostic: Towards a personalised phage therapy against antimicrobial resistance | 2018 |
| 849 | denovoSkin | Personalized, bio-engineered skin grafts for the permanent treatment of skin defects. | 2018 |
| 850 | Stellar i-ris | First non-invasive, reliable and quickest biometric system detecting users’ fatigue and narcotics consumption for road safety and the prevention of accidents at safety-critical workplaces in Europe | 2018 |
| 851 | TARGETSS | Targeting SWI/SNF complex function in cancer | 2019 |
| 852 | THERMONANO | Nanoassemblies for the subcutaneous self-administration of anticancer drugs | 2018 |
| 853 | SARF | Single-Atom Radio Frequency Fingerprinting | 2018 |
| 854 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 855 | PCAPIP | Towards understanding non-canonical phosphatidylinositol kinases in the maintenance of prostate metabolism. | 2018 |
| 856 | TETHIS-SBS-CTC | TETHIS-SBS-CTC: An innovative diagnostic testing platform to identify and characterize circulating tumour cells (CTCs) in blood samples. | 2018 |
| 857 | MolPredict | Neural-based solution to boost drug preclinical research success | 2018 |
| 858 | Oncarin | A scientifically proven Microbiome immunotherapy for the treatment of colorectal cancer | 2018 |
| 859 | MOBIUS | MØBIUS: Transforming medication management for improved patient safety | 2018 |
| 860 | TERES | Production back to Europe – through a novel/green manufacturing process of TERbinafine API synthESis | 2018 |
| 861 | CircaCHIP | Development of Circadian Rhythms on Chip | 2018 |
| 862 | FESTA | Flexible Euv SpecTrometer for Attosecond science | 2018 |
| 863 | OAlipotherapy | Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy | 2018 |
| 864 | VitaminBlock | Development of antibacterial compounds that block essential transport function | 2018 |
| 865 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
| 866 | SMIMS | Single Molecule Imaging Mass Spectrometry | 2018 |
| 867 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 868 | SpiralG | PRODUCTION OF PHYCOCYANIN FROM THE SPIRULINA ARTHROSPIRA SP. REVISITING THE SOURCING, EXTRACTION AND CO-VALORIZATION OF THE WHOLE ALGAE IN THE FRAME OF AN INDUSTRIAL BIOREFINERY CONCEPT | 2018 |
| 869 | SIGNIA | SIGNIA: An innovative drug discovery platform for rapid identification and validation of antimicrobial applications in available pharmaceutical resources and drugs open for repurposing. | 2018 |
| 870 | NeuroProtect | Novel Drug Therapy with Potential to Cure Neuro-Degenerative Diseases | 2018 |
| 871 | ENDONANO | Quantitative detection of bacterial endotoxin by novel nanotechnological approaches | 2019 |
| 872 | SECReTE | Enhancing biological drug production through protein secretion | 2018 |
| 873 | 2shRNA | 2shRNA branched nanobinders as promising therapeutic tools for combined cancer therapy | 2019 |
| 874 | PERICO | Peroxisome Interactions and Communication | 2018 |
| 875 | PET-AlphaSy | PET Imaging of Alpha-Synuclein Fibril Formation | 2018 |
| 876 | TRIM-NET | Training network in drug discovery targeting TRIM Ubiquitin ligases in disease | 2019 |
| 877 | ChemLife | Artificial micro-vehicles with life-like behaviour | 2018 |
| 878 | DELIVER | DELIVERy of advanced therapies for diabetes training network | 2019 |
| 879 | denovoSkin | Personalized, bio-engineered skin grafts for the permanent treatment of skin defects | 2018 |
| 880 | EUROoC | Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe | 2018 |
| 881 | V.A. Cure | A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies | 2019 |
| 882 | PHAGOVET | A cost-effective solution for controlling Salmonella and Escherichia coli in poultry production | 2018 |
| 883 | Microrobots | Engineering Biohybrid MicroRobots from Magnetic Swimmers and S-layers | 2018 |
| 884 | mP-CSE | Micro-physiological circadian platform for safety and efficacy assessment of drugs and cosmetics | 2018 |
| 885 | MaeBAia | Mechanisms of adverse effects of Beta-Agonists in Asthma | 2018 |
| 886 | HydroLieve | A long-lasting non-migrating hydrogel for relieving chronic pain | 2018 |
| 887 | PIcelles | Penetration-promoting and Imageable Polymeric Micelles as a Platform Technology for Individualized and Improved Tumor-targeted Drug Delivery | 2018 |
| 888 | HISTOID | A Human iPS Cell-Derived Artificial Skeletal Muscle for Regenerative Medicine, Disease Modelling and Drug Screening | 2018 |
| 889 | BIOCARD | Deep BIOmodeling of human CARDiogenesis | 2018 |
| 890 | ProtoMet | Protometabolic pathways: exploring the chemical roots of systems biology | 2018 |
| 891 | MEDIKURA | MEDIKURA: Digital Infrastructure for Drug Safety in Europe | 2018 |
| 892 | MuFLOART | Microbiological fluorescence observatory for antibiotic resistance tracking | 2018 |
| 893 | AMR-TB | Theoretical and computational investigation of tuberculosis antimicrobial resistance development based on extensive experimental library of mycobacterium strains | 2019 |
| 894 | PATH-TOX | Artificial Intelligence to transform Drug and Chemical safety testing | 2018 |
| 895 | NanoCarb | Glyco-Nanoparticles for Applications in Advance Nanomedicine | 2018 |
| 896 | ProMeTeus | Membrane protein integrated technologies development for drug design | 2019 |
| 897 | INNOVA4TB | Innovation in Tuberculosis | 2019 |
| 898 | NanoPol | Soft Biocompatible Polymeric Nanostructures: A Toolbox for Novel Generation of Nano Pharmaceuticals in Ophthalmology | 2019 |
| 899 | OXIGENATED | Hemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Therapy | 2019 |
| 900 | REACT | REsponsive theranostic nanosystems for Advanced Cancer Treatment | 2019 |
| 901 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 902 | Syn2Psy | Synaptic Dysfunction in Neuropsychiatric Disorders | 2019 |
| 903 | PEP-NET | Predictive Epigenetics: Fusing Theory and Experiment | 2018 |
| 904 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
| 905 | MOAB | Miniaturised optically accessible bioreactor for drug discovery and biological research | 2018 |
| 906 | BestTreat | BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease | 2018 |
| 907 | BERMES | A Novel BERberine derivative for Malignant MESothelioma | 2018 |
| 908 | SusDrug | Sustainable Approach to Drug Discovery | 2019 |
| 909 | TREAT-PD | Patient-specific treatment for Parkinson's disease using reprogrammed skin cells | 2018 |
| 910 | DYNACEUTICS | Remote control healing: Next generation mechano-nano-therapeutics | 2019 |
| 911 | PARAMIR | Investigating micro-RNA Dynamics using Paramagnetic NMR Spectroscopy | 2019 |
| 912 | SCIPER | Studying Cancer Individuality by Personal and Predictive Drug Screening and Differential OMICs | 2018 |
| 913 | WHILYAS | Wound healing ILYA-style | 2018 |
| 914 | VITAE | VIrTual BrAin PErfusion: Assessing cerebrovascular function by High Performance Computing from 3D brain vessel network data for vascular-targeted drug development in neurodegenerative diseases. | 2018 |
| 915 | MORPHEUS | Deciphering Bacteria-induced Morphogenesis and Protection in marine Eukaryotes | 2019 |
| 916 | AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials | 2018 |
| 917 | DNAProteinCrosslinks | DNA-protein crosslinks: endogenous origins and cellular responses. | 2019 |
| 918 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
| 919 | INFORE | Interactive Extreme-Scale Analytics and Forecasting | 2019 |
| 920 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 921 | iProg | Tailored cell-based therapies for frontotemporal dementia and related genetically defined CNS orphan indications | 2018 |
| 922 | IRL790 | NOVEL THERAPEUTIC FOR THE TREATMENT OF PARKINSONS DISEASE | 2018 |
| 923 | NEFERTITI | NEFERTITI: A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs | 2018 |
| 924 | p38_InTh | Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity | 2018 |
| 925 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 926 | CARE | COMMON ACTION AGAINST HIV/TB/HCV ACROSS THE REGIONS OF EUROPE | 2019 |
| 927 | BioExcel-2 | BioExcel-2 Centre of Excellence for Computational Biomolecular Research | 2019 |
| 928 | GreenX4Drug | Green Enantioselective Halogenation for Drug Discovery and Manufacture | 2019 |
| 929 | iP-OSTEO | Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds | 2019 |
| 930 | Notid | Novel Target for Treatment of Chronic Inflammatory Diseases | 2018 |
| 931 | TUMOURPRINT | High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research | 2018 |
| 932 | FIT2GO | A toolbox for fitness landscapes in evolution | 2019 |
| 933 | BUBBLE CURE | Targeted microbubble vibrations to accurately diagnose and treat cardiac device-related bacterial biofilm infections | 2019 |
| 934 | CancerQR | Next generation cancer therapies targeting cancer networks | 2019 |
| 935 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 936 | IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain | 2019 |
| 937 | MIAMi | Refactoring monoterpenoid indole alkaloid production in microbial cell factories | 2019 |
| 938 | WEAR | Behaviour Phenotyping using Inertial Sensors | 2019 |
| 939 | REALNANO | 3D Structure of Nanomaterials under Realistic Conditions | 2019 |
| 940 | NOVIRUSES2BRAIN | ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals | 2019 |
| 941 | NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 |
| 942 | PHIVIDIAS | Preclinical Human In Vitro Drug Immune Response Analysis Platform | 2019 |
| 943 | WhisperSense | Whispering Gallery Modes (WGM) for label free bioanalytics | 2019 |
| 944 | SINSTRO | Unique approach to improving neurological function after stroke with SIN020 | 2019 |
| 945 | ZebraZoom | ZebraZoom: Kinematic analysis for drug and genetic screening in zebrafish | 2018 |
| 946 | The MATRIX | Inflammatory resolution and remodelling of the adipose extracellular matrix: key determinants of a metabolically healthy phenotype? | 2019 |
| 947 | EPIORGABOLISM | Diabetic nephropathy modelling in hESC-derived 3D kidney organoids | 2019 |
| 948 | EUSAT-RCS | European-Latin American TB Research Collaboration Network | 2019 |
| 949 | HYPROTIN | Hyperpolarized Nuclear Magnetic Resonance Spectroscopy for Time-Resolved Monitoring of Interactions of Intrinsically Disordered Breast-Cancer Proteins | 2019 |
| 950 | EU-OPENSCREEN-DRIVE | Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond | 2019 |
| 951 | 3DLT | 3D Living Tissues | 2019 |
| 952 | STICK2HEAL | Innovative adhesives for ear drum healing | 2019 |
| 953 | incPRINT-DRUG | incPRINT as a platform for RNA-targeted drug discovery | 2019 |
| 954 | UCTIL | Urban Chemical Threat Location and Identification | 2019 |
| 955 | PRIME | Advanced and versatile PRInting platform for the next generation of active Microfluidic dEvices | 2019 |
| 956 | TopSpec | Next generation precision antibody profiling - from science fiction to reality | 2019 |
| 957 | EXCHANGE | Dynamic Complexes and Allosteric Regulation of Small Molecule Transporters | 2019 |
| 958 | Ima-Go | A High-throughput, Functional Imaging Platform to Accelerate Drug Discovery | 2019 |
| 959 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 960 | TOL2 | An effective and safe targeted therapy for treatment of Myasthenia gravis | 2018 |
| 961 | BPET | The Next-Generation of Small, Cost-Effective and Mobile Brain Scanner for an Early Detection of Alzheimer’s Disease | 2019 |
| 962 | CANCEREVO | Deciphering and predicting the evolution of cancer cell populations | 2019 |
| 963 | PHOTOMASS | Imaging Biomolecular Self-Assembly with a Molecular Photonic Scale | 2019 |
| 964 | Capsulight | The first ingestible capsule for eradicating Helicobacter pylori infection through photodynamic therapy | 2019 |
| 965 | XEND | Clinical assessment of PILA PHARMA’s TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent | 2019 |
| 966 | ESCulab | European Screening Centre; Unique Library for Attractive Biology | 2018 |
| 967 | EngineeringBAP | Engineering brain activity patterns for therapeutics of neuropsychiatric and neurological disorders | 2019 |
| 968 | Agglomerates | Infinite Protein Self-Assembly in Health and Disease | 2019 |
| 969 | uCARE | Understanding Circumventing Antibiotic REsistance | 2019 |
| 970 | ProMiDis | A unified drug discovery platform for protein misfolding diseases | 2019 |
| 971 | ARREST-TB | Accurate, Rapid, Robust and Economical diagnostic technoliogieS for Tuberculosis | 2019 |
| 972 | NIMM | Fluorescence-based nano-immunoassay IVD platform | 2019 |
| 973 | OrganoPlate Graft | Organ-on-a-Chip technology for in vitro grafting and vascularisation of 3D tissues | 2019 |
| 974 | BioMensio | BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test | 2019 |
| 975 | HAIKU | A breakthrough alternative to antibiotics for preventing and curing infectious diseases at Intensive Care Units | 2018 |
| 976 | SpartWISE | Reinventing fine chemicals synthesis: large-scale production of sparteine from lupin beans | 2019 |
| 977 | Vitreoject | Disrupting Medical Instruments for Eye Care. | 2019 |
| 978 | Plasmanorg | Environmental-friendly organic chemical synthesis in plasma reactor | 2019 |
| 979 | ViR | We are developing ground-breaking therapeutics to cure currently untreatable respiratory infections affecting children and the elderly | 2019 |
| 980 | MEFISTO | MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy | 2019 |
| 981 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 982 | NeuroDeRisk | Neurotoxicity De-Risking in Preclinical Drug Discovery | 2019 |
| 983 | VOILA | Validation of Innovative Lipopeptide Antibiotics | 2019 |
| 984 | RESOLVE | tPA-Nanoconstructs for Treating Acute Ischemic Stroke: a Technical and Commercial Analysis | 2019 |
| 985 | RAPID | RAPID MIGRAINE RELIEF WITH ALGINATE-BASED THIN FILM | 2018 |
| 986 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
| 987 | AgePhagy | An integrated high-throughput human cell and Drosophila screening platform for the expedited discovery of anti-ageing compounds | 2019 |
| 988 | RGD-Diabetes | Development of RGD-therapeutics for cardio-metabolic disease | 2019 |
| 989 | SCAMPICITY | cAMP-dependend plasticity of striatal projection neurons in health and disease | 2019 |
| 990 | MicroSPARK | A Single-Molecule Technology for Resolving Chaperone Action in Neurodegenerative Diseases | 2019 |
| 991 | DNA-bots | Enzyme-powered DNA nanorobotic devices | 2019 |
| 992 | scTALLmap | Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia | 2019 |
| 993 | Oncogenic PI3-kinase | New biology of oncogenic PI 3-kinase | 2019 |
| 994 | LifeTime | Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease | 2019 |
| 995 | RESIST3D | Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids | 2020 |
| 996 | EV-2C | Structural and functional studies of enterovirus 2C proteins: promising targets for antiviral therapy. | 2019 |
| 997 | DiPipe | Direct remote C-H functionalization in piperidine derivatives | 2019 |
| 998 | BrEXo-Apt | Non-invasive and accurate diagnosis and treatment of breast cancer. | 2019 |
| 999 | hsPCF-FRET | Real-time characterisation of neuropeptide binding to a membrane receptor involved in pain and ischemic stroke | 2019 |
| 1000 | GPCR-MS | Molecular Details of Membrane Protein Receptor Dynamics | 2019 |
| 1001 | CApaCITy | CAncer Stem Cell Imunoreceptors as potential Targets for skin Squamous cell carcinoma | 2019 |
| 1002 | THERMOGUIDE | Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance | 2019 |
| 1003 | GetToKnowPneumo | A pooled CRISPRi screen to identify new cell cycle proteins in the opportunistic human pathogen Streptococcus pneumoniae | 2019 |
| 1004 | deCrYPtion | Decrypting Mycobacterium cytochrome P450 (CYP) physiological functions by testing hypotheses emitted form large-scale comparative genomics analysis | 2019 |
| 1005 | ChOLLATERAL | Generation of an adverse outcome pathway network on cholestatic liver injury for mechanism-based in vitro testing of chemicals. | 2019 |
| 1006 | REBELLION | Light-REsponsive Nanomachines for Targeted Eradication of BactErial Pathogens in LocaLised InfectIONs | 2020 |
| 1007 | BrainWatch | Transient micromachined pressure-monitoring implants for chronic brain disorders | 2019 |
| 1008 | COMBATTB | Comprehensive Mechanisms of Bacterial Antibiotic Tolerance in Mycobacterium Tuberculosis | 2019 |
| 1009 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 1010 | BIOMAP | Biomarkers in Atopic Dermatitis and Psoriasis | 2019 |
| 1011 | NEURONET | Efficiently Networking European Neurodegeneration Research | 2019 |
| 1012 | TRAIN-HEART | TRAIN-HEART | 2019 |
| 1013 | TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease | 2019 |
| 1014 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 1015 | RuCat | New Horizons in C–H Activation: the ‘Real-World Molecules’ Challenge | 2019 |
| 1016 | NANOZID | DNA nanohydrogel loaded Liposomal formulations for high loading efficiency of antimicrobial drugs against intracellular bacterial and topical biofilm infections | 2019 |
| 1017 | pyrroQuin | Synthesis and Biological Evaluation of Pyrroquinoline Pseudo-Natural Products | 2020 |
| 1018 | ACTAN | Automatic Control of Anaesthesia | 2019 |
| 1019 | BacDrug | Bacterial membrane vesicles a novel delivery system for the treatment of multi-drug resistant Gram-negative bacterial infections. | 2020 |
| 1020 | A-PREACH | Asymmetric Photochemical Reactions in confined Chiral space | 2019 |
| 1021 | MagnetoVirology | Diamond Magnetometry: A Versatile Tool for Virology and Medicine | 2019 |
| 1022 | NSFTA | New Strategies For Therapeutic Antibodies – Synthetic bispecific antibodies & Antibody-Drug Conjugates with controlled drug loading. General methods for unexplored ADCs and personalised therapies. | 2020 |
| 1023 | F4TGLUT | Food for thought: monitoring the effects of drugs and diet on neuronal glutamate release using nanoelectrodes | 2019 |
| 1024 | PI3K MODULATORS | Identification and characterisation of new class of PI3K modulators in oncology | 2019 |
| 1025 | SEAROX | Sulfur Enabled Annulations for Modular, Efficient and General Routes into Oxazoles | 2019 |
| 1026 | RAMEN | RAMan spectroscopy for tracking Exosome based delivery of Nutraceuticals | 2019 |
| 1027 | TRIDOS | Targeted Radiotherapy Internal Dosimetry: A platform for individualized patient dosimetry and radiobiological assessment | 2019 |
| 1028 | PRINT-CHEMO | To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. | 2019 |
| 1029 | SNFWD | A pH-Responsive Bionanohybrid Nanofibrous Wound Dressing | 2019 |
| 1030 | STOICISM | Stochastic Communication Inside Cortical Microcolumns | 2019 |
| 1031 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 1032 | CheckBacZ | Checkpoints in the bacterial cell cycle: role of the cytokinetic Z-ring and implications for antibiotic resistance | 2020 |
| 1033 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
| 1034 | AtropFluoPhoto | Stereoselective Synthesis of Atropisomeric Fluorophores for Asymmetric Photocatalysis | 2019 |
| 1035 | MImETIC INDiRECT | MIcrovascularizED Tumour-on-chip for Cellular ImagiNg of Drug Response and Cell moTility | 2019 |
| 1036 | IA-NANO | Albumin particles for intra-articular delivery of celecoxib to treat osteoarthritic inflammation. | 2019 |
| 1037 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 1038 | Finding VENomS | Venom Evolution in Nemerteans: Connecting Functional Morphology, Gene Expression and Proteome through Spatial Omics | 2019 |
| 1039 | 4D-Biogel | 3D and 4D Bioprinting: Additive Manufacturing of Smart Biodegradable Hydrogels | 2019 |
| 1040 | MODSIM | Modelling of Twin Screw Granulation on Micro-Macro Scales | 2019 |
| 1041 | OMECRY | Organic Mesocrystals: Formation and controlling of oriented nanoparticles of molecular solids for drug development | 2019 |
| 1042 | TBNANO | Targeted intracellular delivery of antitubercular agents by functionalized nanocapsules | 2019 |
| 1043 | POLAR STAR | Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer | 2019 |
| 1044 | DNA-NANO-AB | “DNA-based NANOdevices for the point-of-care electrochemical detection of AntiBodies” | 2020 |
| 1045 | 3D NKCC1 | Interdisciplinary approach to characterize the structure and the ion transport mechanism of NKCC1, a key target for brain disorders. | 2019 |
| 1046 | PMLingAML | Using PML nuclear body biology to identify potential AML treatment targets | 2020 |
| 1047 | DynaPIC | Dynamic bonds and polyion complex (PIC) nanoparticles for targeted intracellular peptide delivery | 2020 |
| 1048 | BioNanoProbes | Bio-Inspired Glycan-NanoProbes as Antimicrobial Pro-Drugs | 2019 |
| 1049 | Prion Respiration | The Role of Complex I Assembly Factors during Prion Diseases: Insights into Mitochondrial Neurobiology | 2019 |
| 1050 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 1051 | PMSMatTrain | Novel Biomaterial-based Device for the Treatment of Progressive MS- - An Integrated Pan- European Approach | 2019 |
| 1052 | ORBITAL | Ocular Research By Integrated Training And Learning | 2019 |
| 1053 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 1054 | TT4CL | Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis | 2019 |
| 1055 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 1056 | UreaCa | Deciphering the metabolic roles of the urea-cycle pathway in carcinogenesis for improving diagnosis and therapy | 2019 |
| 1057 | STOPFOP | Saracatinib Trial tO Prevent FOP | 2019 |
| 1058 | BorderSens | Border detection of illicit drugs and precursors by highly accurate electrosensors | 2019 |
| 1059 | RegulatioNFkB | Deciphering transcriptional regulation of NF-kB target genes using integrative omics approaches | 2019 |
| 1060 | SiGNATURE | Selection of human iPSC-derived cardiomyocytes by sinGle cell geNe expression and pAtch clamp for a maTUre caRdiac modEl | 2020 |
| 1061 | EstAMR | Estimating the Prevalence of AntiMicrobial Resistance | 2020 |
| 1062 | DONNA | Engineering de novo production of chlorinated polyketides in Pseudomonas putida | 2020 |
| 1063 | MICROX | Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform | 2019 |
| 1064 | MacMeninges | Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging | 2019 |
| 1065 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 1066 | uKNEEversal | uKNEEversal: a miniaturized 3D in vitro model of human joint to gain new knowledge on Osteoarthritis pathophysiology | 2019 |
| 1067 | MONET | Merkel cell polyomavirus Oncogenic Network | 2019 |
| 1068 | LCxLCProt | Comprehensive two-dimensional liquid chromatography for the characterization of protein biopharmaceuticals at the protein level | 2020 |
| 1069 | MS4Drug | An Innovative Mass Spectrometry-Based Workflow for Drug Discovery | 2019 |
| 1070 | SmOoC | Smart organ-on-chip platform based on higher order multimode acoustic Lamb waves | 2020 |
| 1071 | BITFORM | Multiplexed biosensing and tissue-on-a-chip integrated platform for breast cancer biomarkers monitoring | 2019 |
| 1072 | H. Pylori-Scopy | Biophotonic Spectroscopic tool for Helicobacter Pylori diagnosis - a pathway for low cost clinical robotic device | 2019 |
| 1073 | LEPVORS | Identification and characterization of new drug resistance and host adaptation mechanisms in Mycobacterium leprae | 2019 |
| 1074 | TyphiNET | A global multi-institutional Typhoid fever genomic surveillance network to improve global public health outcomes | 2020 |
| 1075 | GPCR-Sensor | GPCR-based biosensor for synthetic biology applications | 2020 |
| 1076 | MemTrain | Cell Membrane Training to Advance Industrial Processes | 2019 |
| 1077 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 1078 | Dinophyte | Dinoflagellate phytotoxins exploitation | 2019 |
| 1079 | LIBSED | Libiguins: a remedy for the treatment of sexual dysfunctions | 2019 |
| 1080 | KATA | The therapy app for more air and health | 2019 |
| 1081 | RIVELIN-CLO | The Ultimate Therapy for the Oral Lichen Planus | 2019 |
| 1082 | TARGLIO | Improved glioblastoma treatment through targeted, local drug delivery | 2019 |
| 1083 | Hyalcis | Hyaluronic-Cisplatin Film for Implant in Malignant Mesothelioma Recurrence | 2019 |
| 1084 | RAPID | The first effective remedy for acute pancreatitis disease | 2019 |
| 1085 | ISACS | Improving Safety and comfort for kidney transplanted patients by enabling Accurate therapeutic drug monitoring through quantitative Capillary home Sampling | 2019 |
| 1086 | SMASH | The first non-invasive device for continuous, real-time monitoring of glucose and lactate through sweat analysis | 2019 |
| 1087 | HELP | Collaboration for innovation: Establishment of a pan-nematode drug development platform | 2019 |
| 1088 | MOBILISE-D | Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement | 2019 |
| 1089 | ActiveMatter | Active Matter: From Fundamental Science to Technological Applications | 2019 |
| 1090 | ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation | 2019 |
| 1091 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
| 1092 | GHSO | Generation of human steroid-producing organoids: a new approach to treat adrenal insufficiency | 2019 |
| 1093 | InnovaXN | Doctoral programme for innovators with X-rays and neutrons | 2019 |
| 1094 | ARDRE | Ageing, Regeneration, and Drug Research | 2019 |
| 1095 | BodyDMI | Development of deuterium metabolic imaging to map body biochemistry with MRI | 2019 |
| 1096 | COMMER-CELL | Commercialisation of neuronal cell co-cultures | 2019 |
| 1097 | iLCA | Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies | 2019 |
| 1098 | RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | 2019 |
| 1099 | RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs | 2019 |
| 1100 | Clockstop | A Fast Throughput Drosophila Model to Identify Drug Treatments for Age-related Hearing Loss (ARHL) | 2019 |
| 1101 | SCANRESIST | Reversal of anti-cancer drug resistance | 2019 |
| 1102 | ImmuniPrDx | PrDx - Advanced Software for Predicting the Immune Response During Drug Development | 2019 |
| 1103 | SpheriCal | Reference Certification and Commercialisation of “Universal” Mass Spectrometry Calibration Standards | 2019 |
| 1104 | SUSPENCE | SUSPension ENvironment for CEll culture | 2019 |
| 1105 | His-Li mouse | His-Li mouse, the unique humanized mouse model resembling human liver and immune systems | 2019 |
| 1106 | DiAMS | SEMI-DISPOSABLE INSULIN PATCH PUMP: THE BEST SOLUTION FOR DIABETES PATIENTS | 2019 |
| 1107 | O-POINTED | Osteoarthritis patient cohorts in the dish - personalised cellular drug development tools for osteoarthritis precision medicine | 2019 |
| 1108 | SaPhaDe | Know your enemy: systematic discovery of Salmonella anti-Phage Defences for the improved design of phage therapeutics | 2019 |
| 1109 | ZeNewCardio | ZeNewCardio: Discovering Heart Regeneration Therapies Through Zebrafish | 2019 |
| 1110 | SE3DPASTE | Structurally Engineered 3D Printed Architectures for Scalable Tissue Engineering | 2019 |
| 1111 | MELLODDY | MachinE Learning Ledger Orchestration for Drug DiscoverY | 2019 |
| 1112 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 1113 | Chelator | IRON CHELATOR NBMI FOR THE TREATMENT OF IRON OVERLOAD IN BETA-THALASSEMIA MAJOR | 2019 |
| 1114 | KINETICfinder | KINETICfinder: A disruptive method to determine kinetic profiles in drug discoveries | 2019 |
| 1115 | AmInnovation | Disruptive Innovation to Treat Alzheimer’s and Parkinson’s diseases: new target, new patented drug, new therapeutic strategy. | 2019 |
| 1116 | GPCR Transcriptomics | Exploring the role of GPCR expression diversity in receptor physiology and drug response | 2019 |
| 1117 | ALCO-ADO | Unveiling the alcohol-dependent alterations in local dendritic translation of mRNAs in the prefrontal cortex during adolescence | 2019 |
| 1118 | PHOTO-WALK | Metal-catalyzed remote functionalization of aliphatic amines and amides triggered by photocatalytic sp3 C-H activation | 2020 |
| 1119 | PTOoC | Plug-n-Play Tool-kit of Organ-on-Chips | 2019 |
| 1120 | UNPACK PD-L1 | Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells | 2020 |
| 1121 | AL4BIOCH | Assembly Lines for Biocombinatorial Chemistry | 2019 |
| 1122 | INTERGLP1 | Dissecting GLP-1 receptor internalization pathways using genetic and pharmacological tools | 2020 |
| 1123 | SchiSTOP | Beyond mass drug administration: understanding Schistosomiasis dynamics to STOP transmission | 2020 |
| 1124 | IMPACT | Improving DNA Analysis for Correct Healthcare | 2019 |
| 1125 | EggSorter | Device and method for automatized egg cell inspection and sorting | 2019 |
| 1126 | LABELFREE | LABEL FREE IMAGING WITH PHI-SCAT | 2019 |
| 1127 | TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | 2019 |
| 1128 | KOALA FOCUS | KOALA FOCUS: A disruptive e-health approach to treat at home, attention deficits without drugs | 2019 |
| 1129 | BreakingBarriers | Targeting endothelial barriers to combat disease | 2019 |
| 1130 | Nano_Brain | Improving drug delivery to the brain and glioblastoma treatment using temperature. | 2019 |
| 1131 | TOPAS | Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies | 2019 |
| 1132 | APAC | Advanced Pain Control – An innovation in pain control for those suffering from secondary bone cancer | 2019 |
| 1133 | ActiTOX | Active organotypic models for nanoparticle toxicological screening | 2019 |
| 1134 | SPELITEC | Sequence sPecific ELImination of shiga-Toxin E. Coli | 2019 |
| 1135 | GNA NOW | NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW | 2019 |
| 1136 | SIMICA | Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs) | 2019 |
| 1137 | NEXTER | Next generation eco-friendly, microbiome preserving and reduced resistance therapeutics | 2019 |
| 1138 | OPIOIDREWARD | How distress alters opioid drug effects and abuse liability | 2019 |
| 1139 | MAREP | MAssive intracellular REcording for Pharmacology | 2019 |
| 1140 | EXPERT | EXpanding Platforms for Efficacious mRNA Therapeutics | 2019 |
| 1141 | IMpaCT | Imaging life from Molecules to cells - building knowledge on Cryo-electron microscopy methodologies | 2019 |
| 1142 | COBRAIN | Armenia Center for Translational Research on Chronic Neurodegenerative Disorders: A Neuroscience Initiative on Maintaining Healthy Brain Ageing | 2019 |
| 1143 | DrugPhosphoProfiler | Accelerating drug and biomarker discovery through a new proteomic service: DrugPhosphoProfiler | 2019 |
| 1144 | Light4Sight | Light-activated carriers for the controlled delivery of therapeutic peptides in posterior segment eye diseases | 2019 |
| 1145 | EXTRIDIM | Exploring Triterpene Diversity in Monocots | 2020 |
| 1146 | INSENSE | Incentive salience in human cognition during health and disorder | 2019 |
| 1147 | ABOLED | Commercial feasibility of an anti-bacterial treatment | 2019 |
| 1148 | MPT system | Innovative, cost-effective, ultra-compact MRI-guided therapy system for diagnosis and immediate treatment of Parkinson's Disease | 2019 |
| 1149 | LongActNow | Long Acting Medicines for Complex Therapeutics Needed Now | 2019 |
| 1150 | LUBRIGONE | The first lubrication- and coating-free stoppers for Prefillable Syringes | 2019 |
| 1151 | RetinDR | RetinDR: The first topical ophthalmic formulation (eye drops) that effectively prevents and/or treats the retinal neurodegeneration induced by diabetes (diabetic retinopathy) and/or aging | 2019 |
| 1152 | TWO-BIRDS | A feasibility study for SYT-510, a first-in-class drug to treat neuropsychiatric disorders through restoring overall balance in brain chemistry | 2019 |
| 1153 | ADDEGE | Dramatically improving chronic knee pain from osteoarthritis using an active steering telescopic microcatheter device in conjunction with a new ultra-low friction hydrophilic coating | 2019 |
| 1154 | CandidaHunter | A Nanotechnology Based Blood Culture Medium to Detect Invasive Candida in Bloodstream | 2019 |
| 1155 | Tuberculini | A novel in-vitro diagnostic test for drug-resistant tuberculosis and a personalized antibiotic treatment plan. | 2019 |
| 1156 | IRIS Phase-1 | A revolutionary blood test to easily diagnose and prevent deadly complications of organs and tissue transplants. | 2019 |
| 1157 | StreptoMANIAC | Cost and benefit of beta-lactam resistance in Streptococcus pneumoniae: interplay between the resistance determinants and the cell elongation/division components | 2019 |
| 1158 | TRACER | TRAF-STOP therapy to reduCe inflammation in athERosclerosis. | 2020 |
| 1159 | MechanoGPER | Development of GPER agonists as a novel therapeutic option for pancreatic cancer | 2019 |
| 1160 | miPLUNGER | Novel premium pre-filled syringe plunger made by micro- /injection moulding for innovative drug delivery systems and auto injectors | 2019 |
| 1161 | QTB4AMR | Utilizing an innovative chemical platform to defeat antimicrobial resistance | 2019 |
| 1162 | PrevictDrugs | Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection | 2019 |
| 1163 | BIOXPLOR | BioXplor’s AI/Cognitive Software Platform accelerates and greatly reduces the cost of discovery research and clinical trials, with a primary focus on rare and inflammatory diseases data. | 2019 |
| 1164 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
| 1165 | UBIMOTIF | Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities | 2019 |
| 1166 | PROTON | Proton transport and proton-coupled transport | 2019 |
| 1167 | SINERGIA | advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse | 2019 |
| 1168 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 1169 | INSIGHT EU | INSIGHT FOR EYESIGHT – Novel mRNA medicines for eye disease | 2019 |
| 1170 | PepZoSkin | PepZoSkin: Biocompatible Self-powered Electronic Skin | 2019 |
| 1171 | In-Cytes | IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS | 2019 |
| 1172 | INsTRuCT | INnovative Training in Myeloid Regulatory Cell Therapy | 2020 |
| 1173 | 3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | 2019 |
| 1174 | INSPIRE | INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. | 2020 |
| 1175 | HeatNMof | Heating triggered drug release from nanometric inorganic-metal organic framework composites | 2020 |
| 1176 | PRECODE | PancREatic Cancer OrganoiDs rEsearch Network | 2019 |
| 1177 | TIPAT | Training towards Personalized Antibiotic Treatment | 2020 |
| 1178 | BeMAGIC | Magnetoelectrics Beyond 2020: A Training Programme on Energy-Efficient Magnetoelectric Nanomaterials for Advanced Information and Healthcare Technologies | 2019 |
| 1179 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 1180 | PreMeDosE | Precision Medicine via Diagnostic Enzyme Activity Testing | 2020 |
| 1181 | ONCORNET2.0 | ONCOgenic Receptor Network of Excellence and Training 2.0 | 2020 |
| 1182 | SoMMoR | Soft-bodied Miniature Mobile Robots | 2019 |
| 1183 | NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. | 2020 |
| 1184 | FLIX | FLow chemistry for Isotopic eXchange | 2020 |
| 1185 | BLOC | BENCHTOP NMR FOR LAB-ON-CHIP | 2020 |
| 1186 | EndoMapper | EndoMapper: Real-time mapping from endoscopic video | 2019 |
| 1187 | TaMIE | Targeting MarA to Inhibit Efflux | 2019 |
| 1188 | NEUcrest | Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again. | 2019 |
| 1189 | CYPNASH | Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis | 2019 |
| 1190 | AutoCapSyn | Capsule based machines for the automated synthesis of organic molecules for drug discovery and medicinal chemistry | 2019 |
| 1191 | StopAddict | The game changer drug to cure alcohol use disorders | 2019 |
| 1192 | SELMA | Trial Ready Small Vessel MRI Markers: Proof of Concept | 2019 |
| 1193 | TRS | A paradigm change in the treatment of blinding ocular diseases | 2019 |
| 1194 | NIRD | Nanoelectromechanical Infrared Detector | 2019 |
| 1195 | SLAM-Dx | Diagnostic drug response-profiling using SLAMseq | 2019 |
| 1196 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
| 1197 | TEXAD | TEXAD – Tailoring EXosomes for Autoimmune Diseases | 2019 |
| 1198 | PICARD | DISRUPTIVE GPCR LEAD DISCOVERY PLATFORM DELIVERING NEW AND SAFER THERAPEUTICS | 2019 |
| 1199 | AlternativesToGd | Hyperpolarised MR technologies and molecular probes as alternatives for conventional metal-containing contrast agents for MRI examinations | 2019 |
| 1200 | IN-FET | Ionic Neuromodulation For Epilepsy Treatment | 2020 |
| 1201 | LIGHT4LUNGS | Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections | 2019 |
| 1202 | NEUROPA | Non-invasive dynamic neural control by laser-based technology | 2020 |
| 1203 | NEUREKA | A smart, hybrid neural-computo device for drug discovery | 2019 |
| 1204 | PEPSA-MATE | Nanopeptides and Nanosaccharides for Advanced and Sustainable Materials | 2020 |
| 1205 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
| 1206 | THEIA | Design and engineering of porous nitride-based materials as a platform for CO2 photoreduction | 2020 |
| 1207 | Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | 2019 |
| 1208 | Aware | Aiding Antibiotic Development with Deep Analysis of Resistance Evolution | 2019 |
| 1209 | NOVACHIP | Novel vascular-like BBB-on-a-chip | 2020 |
| 1210 | MOLEC ANTI-ARRHYT | Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design | 2020 |
| 1211 | SONOBOTS | Acousto-Magnetic Micro/Nanorobots for Biomedical Applications | 2019 |
| 1212 | VIDEC | Visualizing Death Inducing Protein Complexes | 2020 |
| 1213 | InPreSS | International Pregnancy Safety Study | 2020 |
| 1214 | NoBiasFluors | Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging | 2020 |
| 1215 | ChronicPain | New Target and Drug Candidates for Alleviating Chronic Pain | 2019 |
| 1216 | EASY-Diabetes | Individualised and Equitable Care of Type 2 Diabetes | 2019 |
| 1217 | CELLPHASE_AD | Genetics to understand cellular components of Alzheimer Disease pathogenesis | 2019 |
| 1218 | NanoGut | Exploiting the pathophysiology of the gut towards innovative oral peptide delivery strategies | 2020 |
| 1219 | VIRTUOUS | Virtual tongue to predIct the oRganoleptic profile of mediterranean IngredienTs and their effect on hUman hOmeostasis by means of an integrated compUtational multiphysicS platform | 2019 |
| 1220 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
| 1221 | CADISS | A medical device for the selective dissection of pathological tissues and fibrosis | 2019 |
| 1222 | mfloDx | Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection | 2019 |
| 1223 | ONCORELIEF | A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. | 2020 |
| 1224 | FIDA | Scale-up of our disruptive antibody analytical platform based in flow-induced dispersion analysis (FIDA) to increase efficiency in the research of new antibodies and vaccines | 2019 |
| 1225 | HumanITcare | Disruptive Real World Data & Real World Evidence Internet of Things platform for faster and more accurate clinical studies | 2019 |
| 1226 | SA-VOIR | Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action | 2019 |
| 1227 | BREAK | Blue light remote analgesia with K+ channels | 2019 |
| 1228 | HD-Neu-Screen | HD-MEA-based Neuronal Assays and Network Analysis for Phenotypic Drug Screenings | 2020 |
| 1229 | UNICOM | Up-scaling the global univocal identification of medicines | 2019 |
| 1230 | HominAb | Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases | 2019 |
| 1231 | uHeart | A beating Heart-on-Chip for pre-clinical early detection of drugs cardiac safety | 2019 |
| 1232 | StrataGRT | An innovative topical drug delivery system for improving chronic wound healing | 2019 |
| 1233 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 1234 | ELDICO ED | ELDICO ED, Shaping the Future of Crystallography - The First Pure Electron Diffraction Equipment for Nano-Crystallography | 2019 |
| 1235 | NeuroPa | Targeting the brain sigma-1 receptor: A paradigm shift for the treatment of neuro-degenerative disorders | 2019 |
| 1236 | EDAS HEALTHCARE | AI-based infectious diseases diagnosis in seconds | 2019 |
| 1237 | RESCUER | RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. | 2020 |
| 1238 | TOPOCELL | A cell separation microfabricated platform for cell migration and invasion assays | 2020 |
| 1239 | CardioProtectMI | A New Drug Therapy for the treatment of ST Elevated Myocardial Infarction | 2019 |
| 1240 | RD-MRI NETWORK | BRIDGING THE GAP BETWEEN ACADEMIA & CLINICAL TRIALS FOR THE DEVELOPMENT OF RARE DISEASE TREATMENTS VIA NUCLEAR MAGNETIC RESONANCE IMAGING (MRI) | 2020 |
| 1241 | MEISi | Druggable Small Molecule Inhibitor of MEIS Proteins | 2019 |
| 1242 | Lottare GBM | LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme | 2019 |
| 1243 | PRIME | Prevention and Remediation of Insulin Multimorbidity in Europe | 2020 |
| 1244 | SMA-TB | A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | 2020 |
| 1245 | FAIR | FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA | 2020 |
| 1246 | HAP2 | Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia | 2020 |
| 1247 | IP-cure-B | Immune profiling to guide host-directed interventions to cure HBV infections | 2020 |
| 1248 | MISTRAL | Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination | 2020 |
| 1249 | DocTIS | DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES | 2020 |
| 1250 | TO_AITION | A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities | 2020 |
| 1251 | PANDORA | Pandemics Outbreaks Rationalized: towards a universal therapy to eliminate intracellular pathogens and drug resistance | 2020 |
| 1252 | DPR-VAX | Dipeptide-Repeat Vaccine to prevent ALS and FTD in C9orf72 mutation carriers | 2020 |
| 1253 | NEFERTITI | A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs | 2020 |
| 1254 | ARON | Assay-Ready Organ Network | 2020 |
| 1255 | DC-ren | Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren) | 2020 |
| 1256 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |
| 1257 | QSPainRelief | Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach. | 2020 |
| 1258 | CoroPrevention | Personalized Prevention for Coronary Heart Disease | 2020 |
| 1259 | EIS | An innovative, effective and minimally-invasive retinal cell therapy combined with a new injection system for treatment of retinal degenerative diseases. | 2019 |
| 1260 | DRTB-HDT | STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL | 2020 |
| 1261 | CLAUSTROFUNCT | Claustrum function in cortical processing and putative claustral dysfunction in schizophrenia | 2020 |
| 1262 | EDUC8 | Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity | 2020 |
| 1263 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 1264 | ELFO | Electronic Food: enabling edible electronic systems for biomedical and food monitoring applications | 2020 |
| 1265 | MIGHTY | Roll-to-Roll Manufacturing of Hierarchical Li-Ion Battery Electrodes | 2020 |
| 1266 | iNEXT-Discovery | Infrastructure for transnational access and discovery in structural biology | 2020 |
| 1267 | inhibiTOR | Novel selective mTORC1 inhibitors | 2020 |
| 1268 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 1269 | HyperCube | HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields | 2020 |
| 1270 | PureIgY | Towards the use of IgY antibodies as alternative therapeutics | 2020 |
| 1271 | Glue2Degrade | Therapeutic hijacking of E3 Ligases | 2020 |
| 1272 | PHYRIST | Physiological roles of the Ribotoxic Stress Response | 2020 |
| 1273 | DYNOME | Barcoding gene expression dynamics at single-molecule resolution | 2020 |
| 1274 | GUT-SEQ | Single-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel disease | 2020 |
| 1275 | Trep-AB | Repurposing clinically approved antibacterial drugs for treponematoses therapy | 2020 |
| 1276 | mARs | mARs: Mobile DNA driven antibiotic resistance spreading: molecular strategies, control and evolution for broad distribution | 2021 |
| 1277 | THERA | Therapeutic Drug Monitoring with Smartphone-integrated Surface Enhanced Raman Spectroscopy | 2020 |
| 1278 | DIANA | Organ-on-a-chip Drug screenIng device to tArget braiN diseAse | 2020 |
| 1279 | FAST_TOX | BANKED HEPATOCYTE MONOLAYERS FOR ACCELERATING DRUG TOXICITY SCREENING | 2020 |
| 1280 | PArtCell | Physiologically Crowded Artificial Cells for Relevant Drug Screens | 2020 |
| 1281 | Droplet Microarray | Miniaturized System for Screening of Primary Cells based on Droplet Microarray | 2020 |
| 1282 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 1283 | Design2Flow | Disposable well-plate inserts and perfusion chambers for easy-to-use and generic microchannel creation in 3D tissue culture | 2020 |
| 1284 | NANOVR | Nanoscale Design using Virtual Reality | 2020 |
| 1285 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 1286 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 1287 | ClickandTreatCancer | Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 |
| 1288 | FI4P | Flow and Iron for Pharma | 2020 |
| 1289 | IMMQUIRE | INTEGRATED MECHANICS FOR MODULAR QUANTUM RECONFIGURABLE CIRCUITS | 2021 |
| 1290 | EIM | Towards Elemental Identification in Single Molecules using Atomic Force Microscopy | 2021 |
| 1291 | Cells in Matrix | Cells in Matrix – an innovative 3D model for R&D of Diabetes | 2020 |
| 1292 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 1293 | DeepNOE | DeepNOE: Leveraging deep learning for protein structure solving at ultra-high resolution on the basis of NMR measurements with exact nuclear Overhauser enhancement | 2020 |
| 1294 | PHOTO-CYCLE | Photocatalysis in Drug Discovery - Asymmetric Preparation of Bioactive Chiral Lactones and Cyclohexanols | 2020 |
| 1295 | SusCat | Stereoselective CO2 Capture through Sustainable Organocatalytic Alkene Activation | 2020 |
| 1296 | MAESTRO | Magneto-Acoustically Engineered Steerable Robots | 2020 |
| 1297 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 1298 | Micro-GIFT | Microrobotic Gamete/Zygote IntraFallopian Transfer | 2020 |
| 1299 | ChiCC | Chirality via Cross-Coupling: New Asymmetric C-C Bond Formations Driven by Atom and Step Economy | 2020 |
| 1300 | DiStRes | Disentangling the stringent response to engineer novel anti-persister drugs | 2020 |
| 1301 | Net2Gel | Double network hydrogels for topical drug delivery applications | 2020 |
| 1302 | BESG | Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer | 2020 |
| 1303 | TS4NC | TS4NC: Therapeutic S4N Chelation targeting Alzheimer's Disease. | 2020 |
| 1304 | BISBORONDYKAT | Asymmetric Csp3 – Csp3 Suzuki−Miyaura Coupling Employing 1,1-Bisboryl Alkanes | 2020 |
| 1305 | NANOCRISPR | NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS | 2021 |
| 1306 | Trojan | Redefining Tsetse symbiont bacteria: A Trojan horse against Trypanosome transmission | 2020 |
| 1307 | STARSS | Super Time-resolved Fluorescence Anisotropy with Switchable States | 2020 |
| 1308 | FuelVesicles | Commercialization of open vesicles to fuel downstream reaction networks | 2020 |
| 1309 | PolyTEM | Understanding Crystal Polymorph Control in Confinement using In-situ TEM | 2020 |
| 1310 | MAMBO | Magnetic swArms for liver chemoeMBOlization | 2020 |
| 1311 | SmartHeart | SmartHeart, a 3D in vitro assay for improved assessment of cardiac drug efficacy and toxicity | 2020 |
| 1312 | DINAMIC | A digestion and absorption mimicking bench-top intestinal model | 2020 |
| 1313 | SPOT | SPOT - Synthesis of Pretargeted Oncology Theranostics | 2020 |
| 1314 | GUT3D-PLATE | Ready-to-use cell culture plates for gut 3D models | 2020 |
| 1315 | FluAttack | Validation of a novel antiviral drug candidate against influenza | 2020 |
| 1316 | MANTARGET | Super resolution imaging of nanoPMOs for cancer drug delivery | 2021 |
| 1317 | AsymmFlow | Go with the continuous flow: Asymmetric Synthesis of Bioactive Alkaloids by Multistep Continuous-Flow Processes | 2020 |
| 1318 | hyP5 | Adopting orphan pumps: Structural and functional characterization of P5-ATPases | 2021 |
| 1319 | AlzheimersInAction | AlzheimersInAction: A multi-disciplinary approach to determine the cellular and molecular mechanisms underlying the inflammatory response to amyloid-β in Alzheimer’s disease. | 2021 |
| 1320 | ERA | Epigenetic Regulation in Acinetobacter baumannii | 2020 |
| 1321 | BiLamVesicles | Novel bi-lamellar lipid vesicles for studying double-membrane transenvelope proteins | 2020 |
| 1322 | FUSION | Single Molecule Imaging-based design of HIV-1 vaccines | 2020 |
| 1323 | ANTIBIOCLICKS | BioInspired Clicked Siderophore-Antibiotics | 2020 |
| 1324 | ACQUIRE | Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling | 2020 |
| 1325 | MAP-AD | A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease | 2021 |
| 1326 | HypoCyclo | Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions | 2020 |
| 1327 | NOSCAR | decipheriNg Oncogenic SIgnalling patterns to break CAncer drug Resistance | 2020 |
| 1328 | BlueFlowCell | Synthesis of methylene blue and some new thioether derivatives with an enhanced electrochemical microflow cell | 2020 |
| 1329 | USOME | Advanced Analysis of Polymersome and Exosome Hybrids for Potential Application in Therapeutics and Diagnostics | 2020 |
| 1330 | COMMiT | Cancer Organoids Multiplexed Screening in Microfluidic Textile chips | 2020 |
| 1331 | Ctrl-BBB | Blood-brain barrier: from molecular mechanisms to intervention strategies | 2020 |
| 1332 | HTS MALDI-TOF MDD | MALDI-TOF mass spectrometry metabolite screening assays for drug discovery in human disease | 2020 |
| 1333 | TARGETOF | Mass cytometry nanotools for intracellular target engagement. Towards precision medicine. | 2021 |
| 1334 | EscaPI | Exploring the non-genetic (i.e. ePIgenetic) mechanisms that contribute to therapy Escape in melanoma | 2020 |